
==== Front
BJS Open
BJS Open
bjsopen
BJS Open
2474-9842
Oxford University Press UK

10.1093/bjsopen/zrae028
zrae028
Review Article
AcademicSubjects/MED00910
Bjs/7
Bjs/2
Bjs/5
Bjs/14
Bjs/4
Bjs/13
Bjs/3
Bjs/17
Major surgical conditions of childhood and their lifelong implications: comprehensive review
https://orcid.org/0000-0003-4479-6621
Cullis Paul S Department of Paediatric Surgery, Royal Hospital for Children Edinburgh, Edinburgh, UK
College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK

https://orcid.org/0009-0009-1965-9394
Fouad Dina Department of Paediatric Surgery, Leicester Children’s Hospital, Leicester, UK

Goldstein Allan M Department of Paediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Wong Kenneth K Y Department of Paediatric Surgery, Queen Mary’s Hospital, University of Hong Kong, Hong Kong, Hong Kong SAR

Boonthai Ampaipan Department of Paediatric Surgery, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Lobos Pablo Department of Paediatric Surgery, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

https://orcid.org/0000-0001-6016-6334
Pakarinen Mikko P The New Children’s Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
Department of Women’s and Children’s Health, Karolinska Institute, Stockholm, Sweden
Department of Surgery, University of Southern Denmark, Odense, Denmark

Losty Paul D Department of Paediatric Surgery, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK

Correspondence to: Paul S. Cullis, Department of Paediatric Surgery, Royal Hospital for Children Edinburgh, 50 Little France Crescent, Edinburgh, Lothian EH16 4TJ, UK (e-mail: cullispaul@gmail.com)
6 2024
22 5 2024
22 5 2024
8 3 zrae02811 10 2023
18 12 2023
30 1 2024
© The Author(s) 2024. Published by Oxford University Press on behalf of BJS Foundation Ltd.
2024
https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

In recent decades, the survival of children with congenital anomalies and paediatric cancer has improved dramatically such that there has been a steady shift towards understanding their lifelong health outcomes. Paediatric surgeons will actively manage such conditions in childhood and adolescence, however, adult surgeons must later care for these ‘grown-ups’ in adulthood. This article aims to highlight some of those rare disorders encountered by paediatric surgeons requiring long-term follow-up, their management in childhood and their survivorship impact, in order that the adult specialist may be better equipped with skills and knowledge to manage these patients into adulthood.

Methods

A comprehensive literature review was performed to identify relevant publications. Research studies, review articles and guidelines were sought, focusing on the paediatric management and long-term outcomes of surgical conditions of childhood. The article has been written for adult surgeon readership.

Results

This article describes the aforementioned conditions, their management in childhood and their lifelong implications, including: oesophageal atresia, tracheo-oesophageal fistula, malrotation, short bowel syndrome, duodenal atresia, gastroschisis, exomphalos, choledochal malformations, biliary atresia, Hirschsprung disease, anorectal malformations, congenital diaphragmatic hernia, congenital lung lesions and paediatric cancer.

Conclusion

The increasing survivorship of children affected by surgical conditions will translate into a growing population of adults with lifelong conditions and specialist healthcare needs. The importance of transition from childhood to adulthood is becoming realized. It is hoped that this timely review will enthuse the readership to offer care for such vulnerable patients, and to collaborate with paediatric surgeons in providing successful and seamless transitional care.

In recent decades, survival of children with congenital anomalies and paediatric cancer has improved dramatically such that there has been a steady shift towards understanding their lifelong health outcomes. Paediatric surgeons will actively manage such conditions in childhood and adolescence, however, adult surgeons must later care for these "grown-ups" in adulthood. This article aims to highlight some of those rare disorders encountered by paediatric surgeons requiring long-term follow-up, their management in childhood, and their survivorship impact, in order that the adult specialist may be better equipped with skills and knowledge to manage these patients into adulthood.
==== Body
pmcIntroduction

Advances in fetal, neonatal, paediatric, anaesthetic and surgical care have led to increased survival rates in patients with congenital anomalies. The focus of patient care and research on decreasing the mortality rate of these index conditions has therefore dramatically shifted to reducing the associated morbidity rate. Many children born with congenital anomalies can now be expected to survive into adulthood. For some patients, the long-term effects of the condition may not significantly impact upon their lives. Nevertheless, for many complex conditions, adult survivors must navigate their lives affected by the physical, mental and psychosocial burden of their disease and its treatment. Paediatric surgeons operate on children with congenital anomalies and follow those patients with ongoing needs well into adolescence and young adulthood. As these children become young adults, their healthcare burden may be unmet without a successful, smooth transition to adult services, as some will require further or lifelong follow-up throughout their adult lifetime. Transitional care, which has been defined as ‘the purposeful, planned movement of adolescents and young adults with chronic physical and medical conditions from child-centred to adult-oriented healthcare systems’, is therefore of the utmost importance. This is a process which relies upon multidisciplinary team collaboration, in order to bridge the ‘care gap’ between paediatric and adult healthcare services1,2. Success requires enthusiasm, effort and collaboration between paediatric and adult specialists, to provide anticipatory, structured and multidisciplinary care. Once graduated from this process, the aims would be that the patient and their allocated adult clinicians will be equipped with the information and tools to provide holistic, ongoing follow-up into adulthood, which may be part of a formal adult healthcare programme. This article summarizes a range of major conditions which the paediatric surgeon manages through childhood, and which often require long-term, and in some cases, lifelong follow-up. The hope is to inspire and inform adult surgeons about diseases with which they have limited exposure yet can expect to encounter in increasing number in their surgical practice over subsequent decades.

A comprehensive literature review was performed to identify relevant publications in the English language published until October 2023, using MeSH headings and focused search terms relevant to each section. Several databases were employed, including PubMed, Embase, Cumulative Index to Nursing and Allied Health Literature, Cochrane, Web of Science databases and Google Scholar. Research studies, review articles and guidelines were actively sought, focusing on the paediatric management and long-term outcomes of surgical conditions of childhood. The study methodology was not planned to be a systematic review in accordance with PRISMA guidelines3.

Upper gastrointestinal tract

Oesophageal atresia and tracheo-oesophageal fistula

Oesophageal atresia and tracheo-oesophageal fistula (OA/TOF) occurs in approximately 1 in 4000 births4,5. Most cases are sporadic, with less than 5% of cases occurring as part of a syndrome, such as Down (Trisomy 21) or CHARGE syndrome; however, approximately half of all patients have an additional congenital anomaly identified, which may be part of a recognized constellation of anomalies—the VACTERL association5. OA/TOF is considered a result of aberrant foregut development; however, the mechanisms responsible are poorly understood. The Gross classification is the most popular and divides OA/TOF into five subtypes, of which OA with a distal TOF accounts for 85% of cases (type C) and isolated OA without a TOF (type A) accounts for 8% (Fig. 1). In the former group, a primary anastomosis can usually be achieved at first surgery; in the latter configuration, there is typically a ‘long gap’ between the atretic segments such that delayed primary anastomosis, oesophageal lengthening techniques, gastric transposition or a graft interposition (for example colon or jejunum) are required. Since the first report of successful surgery in the 1940s, clinical outcomes of oesophageal atresia have dramatically improved, such that survival rates of 90–95% are possible in developed countries as a result of advances in neonatal, anaesthetic and surgical care. Nowadays the burden of complex co-morbidity is the major determinant of survival, such that infants with significant structural cardiac disease or extreme prematurity may still succumb6,7. Surgery can be performed by classical open thoracotomy, an axillary crease thoracotomy or thoracoscopic techniques, involving ligation of any TOF(s) followed by anastomosis of the upper and lower oesophageal segments.

Fig. 1 Gross classification system of the five subtypes of oesophageal atresia/tracheo-oesophageal fistula (OA/TOF)

Improvements in survival have unsurprisingly resulted in a growing number of adults living with OA/TOF. The past two decades has seen greater attention focusing on the lifelong implications of OA/TOF survivorship and its associated quality of life (QoL).

Dysphagia is a common symptom in patients with OA/TOF, affecting the majority of patients in the long term, yet is probably underreported as the innate differences in oesophageal motility which the patient has always encountered may not be fully appreciated as a symptom. Many use coping strategies, such as drinking liberal fluids with meals, dietary modifications and allowing additional time for meals8,9. New-onset or worsening dysphagia should be investigated promptly, so that a cause can be readily identified, such as oesophageal stricture; however, oesophageal dysmotility can itself result in swallowing difficulties. Food bolus impaction is a relatively common presentation in children with OA/TOF, yet seems to be less frequent in adults, perhaps due to the development of coping mechanisms to manage what many patients and families colloquially term ‘stickies’. Similarly, many patients experience regurgitation which persists into adulthood, and may represent oesophageal dysmotility or gastro-oesophageal reflux disease (GORD)6.

GORD is often present in children and adults with OA/TOF. When measured by pH-impedance studies or upper gastrointestinal (GI) endoscopy with biopsies, it affects approximately half of all patients yet many are asymptomatic9–11. Endoscopic evaluation is important as there is poor correlation between symptoms and presence of or severity of GORD. Antireflux surgery, notably Nissen fundoplication, has traditionally been undertaken in patients with OA/TOF; however, such operation(s) have become much less common with the availability of proton pump inhibitors (PPIs) and concerns of a wrap worsening dysphagia in the setting of an already dysmotile oesophagus. Unfortunately, there is no good evidence to suggest which, if any, antireflux surgery is best. Limited evidence suggests that complete wraps (for example Nissen) are more effective than partial wraps; however, these may cause worsening dysphagia, retching and gas-bloat symptoms. Conversely, partial wraps (for example Toupet or Thal) may carry less risk of these unwanted sequelae but seem to be less effective in treating GORD. Even with complete wraps, the failure rate may be high, as reported in limited series of adult patients undergoing antireflux surgery12,13. Over recent years, there have been growing concerns with regard to Barrett’s oesophagus and oesophageal adenocarcinoma in adult survivors of OA/TOF. Endoscopic studies have identified a four-fold increase in the prevalence of Barrett’s oesophagus amongst adults with OA/TOF compared with the normal healthy population. Gastric metaplasia is also notably more common. To date, there have been only a few reports of oesophageal cancer developing in patients with OA/TOF; however, the number of survivors into late adulthood is ever-increasing and this association will become clearer over the next few decades14,15. International paediatric gastroenterology guidelines recommend surveillance endoscopy with biopsies taken in four quadrants at the gastro-oesophageal junction (GOJ) and anastomosis every 5 to 10 years in adults with OA/TOF, having a low threshold for endoscopic assessment in the presence of new symptoms, and following adult consensus guidelines on metaplasia where present16–20.

In addition, eosinophilic oesophagitis appears more common amongst patients with OA/TOF than the general population, and treatment may be delayed due to misdiagnosis as oesophageal dysmotility or GORD. Representative biopsies at endoscopy are therefore essential to identify this entity as tailored treatment(s) improve symptoms and development of any stricture(s)16.

Oesophageal dysmotility is universal in OA/TOF. Abnormal manometric patterns are the norm amongst survivors, with reduced peristaltic amplitudes and uncoordinated or absent peristalsis, particularly of the distal oesophagus. Oesophageal emptying appears to be gravity dependent6,8,11,16.

Stricture at the anastomotic site is a common issue in OA/TOF, affecting nearly one in two infants within the first year of life21. Long gap OA and GORD increase the risk. Strictures are typically treated with balloon dilatation or bougienage and repeat procedures are common22. Refractory strictures may be managed by a variety of methods, including steroid injection or topical mitomycin C application, endoscopic incision or stent placement. Surgical resection or oesophageal replacement may be required in the rare instances where such measures fail. Strictures later developing in adult patients are unusual, and can suggest untreated GORD23,24.

Recurrent TOF occurs in less than 5% of patients after surgery for OA/TOF, being more common in the setting of excessive anastomotic tension and after anastomotic leak. New-onset cough, aspiration or recurrent chest infections are typical symptoms. This is, however, likely to be identified in childhood; few cases have been reported amongst the adult population25. Similarly, a missed TOF, particularly of the proximal oesophageal pouch, is also a possibility in patients with the aforementioned symptoms. Again, this is considered rare in paediatric patients, such that adult clinicians are unlikely to encounter it. Wider use of preoperative diagnostic tools (such as tracheo-bronchoscopy), greater awareness of a missed TOF by clinicians and therefore a lower threshold for targeted investigations should reduce their incidence and impact, however26.

The respiratory morbidity rate amongst OA/TOF survivors is increasingly recognized; however, the mechanisms by which it arises are again poorly understood. Young children with OA/TOF often experience tracheomalacia or airway collapse, managed by watchful waiting, positive ventilation strategies, and aortopexy or posterior tracheopexy surgery in some cases; however, this does not tend to be a major issue into adulthood. Adults may experience wheezing, regular cough, lower respiratory tract infections and episodes of bronchitis. It is important to exclude anatomical causes for new-onset symptoms (such as oesophageal stricture, recurrent or missed TOF, or vocal cord paralysis) although many will not have a cause identified. Studies, however, have generally identified mild reductions in pulmonary function testing, usually of a restrictive pattern, and exercise tolerance in most survivors is mostly considered unimpaired6,27,28.

Musculoskeletal problems after surgery for OA/TOF are common, such as scoliosis, chest wall deformity, winging of the scapula and shoulder dysfunction, rib fusion and breast disfigurement. Thoracotomy alone is responsible for many of these, and may be one major advantage of adopting minimally invasive approaches15,29.

QoL in adults with OA/TOF is often considered very good. That said, specific domains are affected more than others, particularly relating to the GI and respiratory system, as well as some patients experiencing reductions in psychosocial wellbeing. Long gap OA, revisional surgery, repeated hospital admissions and co-morbidities have a significant negative impact on QoL6,7.

Long gap OA may require oesophageal replacement with gastric transposition, jejunal interposition or colonic interposition. Such patients may experience a greater long-term morbidity rate than those with classical variant OA/TOF. There are inherent problems seen with each substitution graft, a subject widely reported in the literature30.

As a result of these lifelong sequelae, transition to adult services and close follow-up is essential for many adults born with OA/TOF ideally coordinated by clinicians with enthusiasm for this special patient group in a multidisciplinary clinic involving surgeons, gastroenterologists and/or respiratory physicians10,12,16. The International Network on Oesophageal Atresia has produced consensus guidelines for the transition of patients with OA/TOF which are a helpful resource for adult clinicians, as well as the aforementioned European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) guidelines, and European Reference Network for Rare Inherited Congenital Anomalies (ERNICA) consensus document on OA/TOF16,31,32.

Malrotation and midgut volvulus

Normal intestinal orientation is understood to occur in various stages. Physiological herniation of the embryonic intestine into the umbilical cord in the fourth week of gestation is associated with a 90-degree rotation. As the mid-gut returns to the abdominal cavity by the 10th week of gestation, an additional 180-degree rotation occurs. This is followed by a fixation process to the abdominal wall. This is the classic and simplified understanding of how the standard anatomical configuration of the bowel is achieved33. Intestinal rotational anomalies encompass a spectrum of congenital disorders whereby the normal embryological process of intestinal rotation and fixation are disrupted. At one end of the spectrum is non-rotation, where the small bowel lies to the right and the colon to the left of the abdomen cavity. This is, in fact, the orientation that is achieved by undertaking Ladd’s procedure, described later, and is often present when abdominal wall development is disrupted in utero, as in abdominal wall defects or congenital diaphragmatic hernia (CDH). The risk of volvulus here is typically considered to be low, but depends on the breadth of the mesentery and degree of fixation (which can only be convincingly demonstrated at laparoscopy or laparotomy). At the other end of the spectrum is the normal configuration of the bowel, where the duodenojejunal flexure lies to the left of the midline vertebral column in the upper abdomen, and the caecum fixed in the right lower quadrant. Between these two lie many possible variations, of which the most important clinically is malrotation. Malrotation refers to an orientation of the mid-gut which is liable to volvulus, in which the mesentery of the small bowel, centred around the superior mesenteric vasculature axis, is narrowed and therefore precariously at risk of volvulus. Malrotation is also commonly associated with Ladd’s bands, peritoneal attachments which tether the caecum to the posterior abdominal wall in the right upper quadrant, entrapping the proximal duodenum34. Figure 2 illustrates these variant morphologies.

Fig. 2 Variant anatomy of the midgut in three distinct morphologies: normal rotation, malrotation and non-rotation

The true prevalence of these disorders is not known. It is conservatively estimated that symptomatic intestinal rotational anomalies are present in 1 in 5000 live births33; however, asymptomatic intestinal rotational anomalies occur much more frequently than this35,36. For example, 4% of the population have an atypical location of the appendix which is attributable to a mild rotational anomaly37.

Malrotation often presents in infants, but it can lead to symptoms at any age. The classical emergency presentation is of a neonate with bilious vomiting due to mid-gut volvulus; however, older children and adults can present with less typical symptoms, such as non-bilious vomiting, feed intolerance, chronic abdominal pain, early satiety, diarrhoea, failure to thrive and weight loss38,39. In one of the largest series, malrotation was diagnosed as frequently in adulthood as it was in childhood38. In paediatric practice, diagnosis is established by an upper GI contrast study, sometimes with ultrasound as an adjunct. Cross-sectional imaging can also demonstrate intestinal rotation; however, only laparoscopy or open surgery allows the surgeon to adequately assess intestinal fixation, or lack thereof. Surgery for malrotation typically involves a Ladd’s procedure, described by William E. Ladd in 1932. This traditionally comprises a laparotomy (usually by a transverse approach), detorsion of the mid-gut volvulus (if present) allowing reperfusion of the ischaemic bowel, division of Ladd’s bands, straightening of the duodenum loop, widening of the small bowel mesentery, replacement of the bowel in a non-rotated configuration, and often appendicectomy (by standard or inversion technique). Management of the asymptomatic patient is controversial, particularly in the setting of heterotaxy disorders, as a conservative approach may be appropriate in some, depending on co-morbidities, especially severity of cardiac anomalies, age, parental choice and the estimated lifetime real risk of volvulus40,41.

Adhesive bowel obstruction can affect a significant minority of patients after Ladd’s procedure, similar to small bowel surgery in adults. Studies with the longest follow-up demonstrate a risk of 10–20%42,43. Of interest, the use of laparoscopy is gaining popularity, particularly for patients in whom volvulus is not suspected. This appears to be associated with a lower risk of adhesive bowel obstruction; however, the risk of recurrent volvulus appears somewhat higher43,44.

Recurrent volvulus after surgery for malrotation with volvulus affects a minority of patients (less than 5%); however, it appears that minimally invasive techniques carry greater risk (3.5% estimate versus 1.4%). Less ‘helpful’ adhesions and inadequate widening of the mesentery have been implicated. Nevertheless, the risk of recurrent volvulus seems to reduce with advancing age, such that few case reports exist of adults developing recurrence43.

Many surgeons routinely perform appendicectomy at the time of surgery for malrotation; however, adult general surgeons should be aware that this is not universally the case, and the appendix may lie in an unusual location after a Ladd’s procedure. Appendicitis would be expected therefore to present with symptoms and peritonism focused on a location other than the right iliac fossa. The same may be true for gastroschisis, exomphalos and CDH, described elsewhere in this article.

Ischaemic necrosis of the small bowel due to mid-gut volvulus may lead to short bowel syndrome (SBS), described comprehensively in the following sections of this article.

A small proportion of patients in the long term may continue to have symptoms after surgery for rotational anomalies45,46. There appears to be a linear relationship between age at presentation and likelihood of postoperative symptoms46. That said, the majority of patients (more than 90–95%) experience resolution of their symptoms by having a Ladd’s procedure and it can be challenging in those experiencing symptoms to attribute these to their intestinal rotational anomaly.

It is important to note that, in the absence of significant loss of bowel due to volvulus, it would be unusual for a patient diagnosed with malrotation to require transition to adult services, but adult surgeons should be made aware that malrotation can present at any age.

Paediatric short bowel syndrome

In SBS critical reduction of the gut length leads to intestinal failure (IF), characterized by severely impaired intestinal absorption and malnutrition requiring prolonged (more than 60 days) parenteral nutrition (PN) for survival and adequate growth47. Other important, but much less frequent, causes of IF in children are primary motility disorders such as paediatric intestinal pseudo-obstruction and congenital mucosal enteropathies47,48. According to population-based estimations, incidence of SBS among children is around 25 per 100 000 live births in developed countries49,50. As the most common underlying aetiologies of paediatric SBS include necrotizing enterocolitis (NEC) encountered in premature newborns, and congenital developmental disorders such as gastroschisis, intestinal atresia and mid-gut volvulus due to malrotation, the disease onset mostly takes place during early infancy47,48. While most children with SBS-IF eventually wean off PN with modern multidisciplinary care, those with less than 30% of age-adjusted remaining small bowel length, loss of ileum and ileocecal valve, and colonic resection may remain PN dependent for many years or permanently51,52. In selected children weaning off PN may have been supported by autologous intestinal reconstructive (AIR) surgery such as serial transverse enteroplasty (STEP) and longitudinal or spiral intestinal lengthening and tailoring51,53. Recent application of the enterotrophic glucagon-like peptide 2 analogue teduglutide therapy among children is likely to further promote achievement of enteral autonomy in paediatric SBS-IF54. Although ongoing developments in expert multidisciplinary management of IF have led to decreased rates of intestinal transplantation55, it remains a valuable rescue strategy for chronic IF in patients with life-threatening complications, while home PN remains a first-line therapy for paediatric IF54. Currently, overall long-term transplant-free survival of paediatric SBS-IF patients is estimated at over 95% in experienced tertiary centres51,56,57.

While patients with paediatric SBS-IF remain exposed to various nutritional, metabolic and other health issues, central venous access (CVA) problems, liver disease and different pathologies of the remaining bowel represent the most important life-threatening or surgically relevant long-term complications in paediatric SBS-IF51,52,56. With improved prognosis of intestinal failure associated liver disease (IFALD), central line complications have become a central cause for PN failure necessitating intestinal transplantation in paediatric SBS-IF58,59. Incidence of central line-associated bloodstream infections (CLABSI) is approximately 1–5/1000 catheter days in children with chronic IF58. As advised in the recent European position paper, in this patient group every febrile episode >38°C should be initially managed as potential CLABSI with central and peripheral blood cultures and empiric antibiotics while avoiding unnecessary central line removals to preserve precious CVA sites58. Prophylactic lock therapies with taurolodine or ethanol reduce CLABSI rates and should be at least considered for recurrent infections and high-risk patients with chronic IF51,58. Up to half of all paediatric IF patients develop central line-related thrombosis, which may lead to an already limited number of CVA sites at the time of transition to adult services58. In order to improve the longevity of CVA sites, catheter-related thrombosis should be treated with low molecular weight heparin and patients with recurrent thrombosis maintained on prophylactic anticoagulation58.

With improved understanding of the underlying pathophysiology, multidisciplinary management and advent of multisource fish oil containing parenteral lipids, progression of cholestatic liver injury to cirrhotic end-stage liver disease has become largely preventable in children with SBS-IF51,57,59,60. However, very premature highly PN-dependent newborns remain at increased risk51,60. In this respect, efficient prevention and treatment of central line and bowel-derived bloodstream infections is crucial as recurrent septic episodes promote cholestatic liver injury60. While cholestasis and portal inflammation predominate initial liver histopathology of IFALD, fibrosis and steatosis are similarly frequent findings during and after weaning off PN encountered at least in half of the patients61. Thus, continuous monitoring of hepatobiliary function primarily with serum liver biochemistry and measurement of liver stiffness as a surrogate of hepatic fibrosis should not be limited to PN-dependent patients, although pathophysiology and progressiveness of the fibro-steatotic form of IFALD remain currently unclear60,61.

In addition to small intestinal bacterial overgrowth (SIBO) and excessive adaptation-related small bowel dilatation, intestinal inflammation and anastomotic ulceration are increasingly recognized as clinically significant intestinal complications in children with SBS52,62–65. Excessive intestinal dilatation often coexists with mucosal inflammation associated with clinical symptoms of SIBO including diarrhoea, abdominal bloating and feeding intolerance, and this aggravates malabsorption52,53,66. Symptomatic dilatation resistant to antibiotic therapy may require tapering of an abnormally enlarged duodenal or small intestinal segment, not only to treat symptoms of SIBO by improving gut motility, but also to prevent liver injury by reducing bowel-derived bloodstream infections52,53,66. Although most patients wean off PN and experience improvement of their GI symptoms after AIR surgery, bowel dilatation and symptoms of intestinal dysfunction recur in a significant proportion of patients52,53,67. Intestinal inflammation and anastomotic ulcerations may cause intestinal bleeding, promoting recalcitrant iron deficiency anaemia, which may require parenterally infused iron supplementation68.

Management of anastomotic ulceration is challenging, and the diagnostic workup may require capsule endoscopy and enteroscopy in addition to routine upper and lower endoscopic examinations65. Although culture-proven SIBO often responds to oral antibiotics, it is associated with the presence of chronic intestinal inflammation resembling inflammatory bowel disease63,64. Medical therapy for both intestinal inflammation and anastomotic ulceration may be escalated from antibiotics, anti-inflammatory medications, corticosteroids to biologics based on severity of inflammation and the treatment response63,65,69. Other treatment options for anastomotic ulceration include endoscopic procedures, such as argon plasma coagulation and surgery, while recurrences are common after all treatment modalities and may later occur several years after initially successful therapy65,69.

Paediatric SBS predisposes to a multitude of complex morbidities and health problems which may manifest only after transition to adult care services and also in patients who have successfully weaned off PN prior to transition. Long-term outcomes of paediatric IF patients into adulthood have not yet been sufficiently studied or addressed and may markedly differ from those of adult IF due to an earlier disease onset at a vulnerable developmental period with higher cumulative disease duration and a largely different aetiology. For optimal continuation of care and outcomes, paediatric SBS-IF patients, including those who have weaned off after a prolonged period of PN, should be transitioned to a specialist interdisciplinary adult intestinal rehabilitation unit with access to intestinal transplantation. Kinberg et al. have published an informative review of the transition process for paediatric and adult clinicians70. Furthermore, there are many examples of adult care programmes for SBS globally, and several published guidelines for adult management71,72.

Duodenal atresia

Duodenal atresia is a cause of duodenal obstruction in the neonatal period, occurring in between 1 in 5000–10 000 live births73. Although several theories have been proposed, embryologically the most accepted theory is a failure of recanalization of the duodenum lumen during the second month of gestation74. This can lead to a web, stenosis or complete atresia. External duodenal obstruction can also occur from developmental anomalies of surrounding structures leading to pancreatic anomalies, malrotation or Ladd’s bands74,75. There are three types of duodenal atresia: type 1 is a web or membrane causing an intrinsic obstruction, type 2 are two atretic portions of duodenum connected by a fibrous cord and type 3 is a complete separation of proximal and distal duodenal segments. It is important that if a type I duodenal atresia (web/stenosis) is identified during the surgery that a ‘windsock’ abnormality is ruled out: this is when the web and site of obstruction can extend more distally than the junction between the proximally dilated and distally collapsed duodenum.

Duodenal atresia usually presents in newborns with features of upper gastrointestinal obstruction; however, it should be noted that although the majority will have bilious vomiting or aspirates, as 85% of duodenal atresias have a postampullary obstruction, 15% are preampullary and these patients may therefore not have bilious vomiting or aspirates at presentation. The characteristic plain X-ray radiograph is that of a ‘double bubble’ and some babies may have had the index diagnosis suspected antenatally. It is well known that duodenal atresia can be associated with other anomalies, with over a quarter of patients having Trisomy 21 and half having another anomaly either in isolation (for example cardiac) or as part of an association (for example VACTERL association). Some children (for example those who have a duodenal stenosis) may present later in childhood73,76.

Surgery for duodenal atresia can be completed via an open or laparoscopic approach, with excellent outcomes achieved by both77,78. When surgery is performed via an open approach, this is usually via either a right upper quadrant transverse laparotomy incision or a transverse supra-umbilical incision. Various anastomoses and techniques have been described to bypass the duodenal obstruction; however, one of the most widely accepted is the diamond-shaped duodenoduodenostomy described by Kimura79 (Fig. 3). Some surgeons may perform a side-side duodenoduodenostomy, duodenoplasty, membrane resection or a duodenojejunostomy instead76,80.

Fig. 3 Kimura duodenoduodenostomy—a popular procedure for duodenal atresia

Overall outcomes following repair of duodenal atresia are considered excellent, with postoperative survival rates of more than 95% expected. Death is usually related to associated anomalies rather than due to the duodenal obstruction76. A recent systematic review on the long-term outcomes of children who had correction of duodenal obstruction reported a 3% late mortality rate, and most of these deaths were due to cardiac anomalies or complications of cardiac surgery81.

Variable terminology for mechanical issues related to the bypass are described in the literature, including anastomotic dysfunction, stricture, duodenal diverticuli and megaduodenum. Overall, these collectively affect up to 5% of patients; however, without a strict definition, it is challenging to draw firm conclusions about the problem. Symptoms may include early satiety, bilious vomiting, halitosis and abdominal pain caused by eating. Upper GI contrast series and CT with oral contrast are helpful in diagnosis81. Balloon dilatation with or without use of endoscopic cautery has been reported; however, reoperation on with anastomotic revision may be required if symptoms are problematic and do not resolve with conservative management. The aforementioned and popular Kimura technique seems less prone to anastomotic issues. Blind loop syndrome is a rare problem which only occurs after less commonly employed bypass techniques (such as duodenojejunostomy) and can present with vomiting, early satiety, an abdominal mass or halitosis81. Moreover, in the few long-term series of duodenal atresia, peptic ulcer disease has developed in a very small number of patients; however, these historic series predate widespread use of PPI therapy82. A significant proportion of patients after duodenal atresia surgery have evidence of duodenogastric +/− biliary reflux on contrast and isotope studies, some of which develop reflux gastritis or duodenal irritation on endoscopic biopsies83.

Adhesive bowel obstruction is reported to occur in up to 5% of cases; however, follow-up in published series is limited, such that this is likely to be an underestimate of the true incidence. It is likely that laparoscopic surgery carries a reduced risk of adhesions; however, there is insufficient long-term data yet published81.

QoL in isolated duodenal atresia is generally comparable with peers. Patients with Down syndrome appear to have reduced social scores overall, but not in gastrointestinal domains81,84.

It is important to note that the literature on long-term outcomes of duodenal atresia is sparse; however, paediatric surgeons do not universally follow such patients into adolescence and the outcome in the long term is, in most, considered excellent. It would be unusual for a patient diagnosed with duodenal atresia to require transition to adult services.

Gastroschisis

Gastroschisis occurs in approximately 1 in 4000 live births85 and is a congenital malformation where the abdominal viscera herniate through a right-sided abdominal wall defect with an intact umbilical cord and no covering membrane or sac over the organs (Fig. 4). This is usually an isolated malformation, so-called ‘simple gastroschisis’; however, 10–15% can be termed ‘complex gastroschisis’, where there is an associated atresia, ischaemia, necrosis, perforation or volvulus86–89. Several embryological theories as to how gastroschisis occurs have been proposed; however, its aetiology remains poorly understood90. Antenatal diagnosis is the norm. Following perinatal transition and stabilization, the goal is to return the herniated viscera into the abdominal cavity. This can be performed in newborns via early primary closure or a staged approach using a silo (soft plastic chimney) followed by delayed closure91.

Fig. 4 Newborn baby with gastroschisis

Note herniated intestinal viscerae with umbilical wall defect to right of the cord structures.

The specific outcomes in gastroschisis are largely dependent upon the condition of the bowel at the time of closure. Overall long-term survival is 90–95%87,92,93. As expected, complex gastroschisis has higher morbidity and mortality rates88,89.

The major determinant of postnatal course is gut dysmotility and poor feed tolerance. This occurs because the bowel has been exposed to the biochemical effects of amniotic fluid in utero94. Newborns with simple gastroschisis take an average of 26 days to reach full enteral feeds and typically require some 28 days of total parenteral nutrition (TPN). For complex gastroschisis, these figures are 165 days and 90 days respectively95.

In the longer term, there is a moderately high risk of adhesive bowel obstruction in patients with gastroschisis, estimated to affect 25% of patients, with follow-up limited to childhood in almost all series. This risk appears to be highest in complex gastroschisis and within the first few years of life96. Patients are also more likely to develop chronic abdominal pain and constipation than the general population96–98.

Gastroschisis can cause SBS in a minority of patients with significant gut loss, as a result of a ‘closing’ or ‘vanishing’ gastroschisis, or from ischaemic complications after birth. It is estimated that just over 1% of patients develop SBS95, which has been comprehensively described previously.

Undescended testes are seen in approximately 20% of boys with gastroschisis at birth, and often the gonad(s) may be seen at primary defect closure. Half will descend spontaneously into the scrotum, otherwise, a single- or two-stage orchidopexy may be required in childhood. Success rates of surgery are lower than that of standard orchidopexy99,100. Therefore, adult survivors may have undergone orchidopexy, or experienced testicular atrophy during childhood.

Cosmesis is a major concern for some adult patients with gastroschisis, particularly where the umbilicus is absent, and plastic surgical interventions with umbilicoplasty may be appropriate in some cases97. Umbilical hernia is not infrequently seen in patients with gastroschisis, particularly after sutureless closure techniques; however, spontaneous resolution over time may occur. In those cases where closure does not occur, umbilical herniotomy is offered in later childhood, such that the adult surgeon is unlikely to be consulted for this issue101,102.

The long-term outlook for gastroschisis is usually considered excellent. QoL is generally considered comparable to the normal population in adult survivors with gastroschisis, despite some patients having concerns about cosmesis or gastrointestinal symptoms97,103,104. Similar to malrotation, in the absence of SBS, it would be unusual for a patient diagnosed with gastroschisis to require transition to adult services.

Exomphalos

Exomphalos occurs in 1 in 4000 live births and the majority are diagnosed antenatally85. It is characterized by herniation of the abdominal viscera with a covering membrane sac (Fig. 5). In contrast to gastroschisis, it has an association with other anomalies with greater than a third of babies having a chromosomal anomaly, such as Down syndrome or Beckwith–Wiedemann syndrome (BWS)105,106. Cardiac, renal and spinal anomalies can also occur. Exomphalos is often classified as minor or major, according to the defect size, which impacts upon primary management strategy107.

Fig. 5 Infant with exomphalos major

Note large abdominal wall defect containing liver covered with membranous sac.

The options for surgical management include primary, staged or delayed closure. Small defects are usually amenable to primary sutured closure. Larger defects can be closed primarily with use of a patch (biologic or synthetic); however, a staged approach is popular107–109. The sac itself can be used as a silo or the preformed silo deployed in gastroschisis can be used to allow gradual reduction of the viscera. Another option is to allow the sac to epithelialize before planning surgery in later infancy or beyond. Approximately a quarter of these patients will still require a patch at final repair and abdominal wall component separation surgical techniques are sometimes employed to permit definitive repair. There is a risk of recurrent ventral wall hernia107,110.

Patients with exomphalos do not tend to have as many gastrointestinal problems in the long term when compared with gastroschisis. Gastro-oesophageal reflux can be problematic. Gastrojejunal feeding may also be considered in this scenario. There is a high rate of children with exomphalos requiring placement of gastrostomy or gastrojejunostomy feeding devices in childhood, as well as those needing antireflux surgery for GORD, which can be technically challenging105,111. Similar to gastroschisis, there is a long-term risk of adhesive bowel obstruction (estimated at 5%) and mid-gut volvulus (estimated at 3%), which is a rare occurrence as intestinal rotation is normally arrested in a safe configuration112.

Similar to gastroschisis, boys with exomphalos have a higher incidence of undescended testes than the normal population. The likelihood of spontaneous scrotal descent is considered much less likely than that of gastroschisis, warranting orchidopexy. Adult surgeons may therefore encounter patients who have undergone surgery for cryptorchidism in early life100.

As mentioned, exomphalos is often associated with other anomalies and syndromes. Trisomy 21 and its health implications are well recognized amongst paediatric and adult clinicians alike, however, BWS (affecting approximately 10% of patients with exomphalos) is less frequently encountered and therefore not so well known amongst adult clinicians113. BWS is the commonest genetic overgrowth condition, with the typical features: macroglossia, macrosomia, postnatal overgrowth, exomphalos, organomegaly and urologic anomalies. It is a cancer predisposition syndrome, most commonly associated with Wilm’s tumour; however, hepatoblastoma, rhabdomyosarcoma, neuroblastoma, adrenocortical and Sertoli cell tumours can arise. The malignancy risk appears greatest in childhood; however, there are reports of adult-onset tumours. To date, there are no definitive international recommendations regarding cancer surveillance, even in childhood, but scheduling regular patient examination, blood tests (including α-fetoprotein level) and abdominal ultrasound is common practice until approximately 8 years of age96,114,115.

QoL in exomphalos appears to be considered generally good and comparable to peers. Nevertheless, approximately a third of patients with exomphalos will report ongoing intermittent abdominal pain that continues into adulthood and half are unsatisfied with the cosmetic appearance of their abdominal wall scar. This is particularly the case for those in whom the umbilicus has been sacrificed, that is in whom the sac has been completely excised116. It would be unusual for a patient diagnosed with exomphalos to require transition to adult services.

Hepatobiliary

Choledochal malformations

Choledochal malformations (CMs), formerly known as choledochal cysts, are congenital biliary tract anomalies with abnormal dilatation of the hepatobiliary tree. The morphological classification of CMs was first proposed by the Japanese surgeon, Takuji Todani117, whose classification is widely adopted by the international surgical community (Fig. 6). CMs occur more commonly in females (3–4:1) and the estimated incidence is much higher in Asia (1:1000) than in Europe (1:37 400)118,119. The majority of CMs become symptomatic and are treated during childhood120. Typically, infants present with painless jaundice whereas older children may experience recurrent abdominal pain which can be secondary to cholangitis or acute pancreatitis, while around 15% are now detected on antenatal ultrasound.

Fig. 6 Todani classification divides choledochal malformations into five distinct groups: type i (80–90%)—dilatation only involving the extrahepatic bile duct, type II (3%)—a diverticulum of the extrahepatic bile duct, type III (5%)—a choledochocoele which involves dilatation of the intraduodenal part of the common bile duct, type IV (10%)—dilatation involving both the intra- and extrahepatic bile ducts, and type v (rare)—Caroli’s disease

The aetiology of CM remains debatable. The two leading theories involve either the presence of an anomalous pancreatobiliary junction (PBM) with associated reflux of pancreatic juice into the biliary system or congenital biliary obstruction with resultant pressure-driven proximal bile duct dilatation118. In PBM, the choledochal sphincter is located distal to the junction of the common bile duct and the pancreatic duct forming an abnormally long common channel. As a result, digestive pancreatic enzymes may reflux freely into the bile ducts, resulting in inflammation, tissue destruction, dilation and cancer (the Babbitt hypothesis)121,122.

CMs require timely surgical excision as, if left untreated, they can lead to various major complications, including obstructive cholestasis, bile duct perforation, recurrent cholangitis, pancreatitis and development of cholangiocarcinoma. In symptomatic children, surgery is performed as soon as the patient’s clinical condition allows. Many cases are, however, diagnosed in asymptomatic children. Surgery is typically planned in such cases on an elective basis123. A wide variety of imaging modalities are available for assessing CMs, while most lesions are primarily diagnosed by ultrasound examination. Additional preoperative imaging is aimed at outlining the biliary tree, identifying coexistent stone disease, and delineating the anatomy of the PBM for safe removal of the intrapancreatic portion of the common bile duct as distally as possible while avoiding pancreatic duct injury. In addition, intraoperative cholangiography and choledochoscopy for thorough clearance of retained stones and debris are routinely used. Although CT scan and 3D-reconstructed MRI have been used increasingly for more precise preoperative delineation of CM morphology, up to 40% of PBMs are still missed with these imaging modalities124. Further assessment using endoscopic retrograde cholangiography, percutaneous transhepatic cholangiography and temporary biliary stenting before surgery may be employed in complicated cases120.

Due to the risk of malignant degeneration, surgical management of CMs involves complete excision of the extrahepatic biliary tract combined with biliary-enteric reconstruction. Currently used options to restore biliary-enteric continuity include hepaticojejunostomy with Roux-en-Y reconstruction, and hepaticoduodenostomy, which are actively debated. Classic open hepaticojejunostomy has been widely advocated and is still used by the majority of European paediatric surgeons124. An increasing trend and preference towards minimally invasive and robotic surgery, especially in Asian centres, has driven hepaticoduodenostomy as an alternative method of biliary-enteric reconstruction. In this respect, it offers several advantages including technical ease of a single anastomosis and shorter operative time with postoperative endoscopic access to the anastomosis should a stricture or stones develop, while predisposing to bilious gastritis, reflux of pancreatic enzymes into intrahepatic bile ducts and a longer remnant of the common hepatic duct125. Comparable outcomes following both biliary-enteric reconstructions have been reported126–128, although cumulative long-term experience is much larger with hepaticojejunostomy. For a narrow common hepatic duct in younger children, hepatic ductoplasty with hepaticojejunostomy is preferred to widen the biliary-enteric anastomosis and prevents stricture when the ductal size is considered small129.

The main long-term complications of CMs include cholangitis, stone formation, stricture of the biliary-enteric anastomosis and malignancy125. Cholangitis, which usually responds to antibiotic therapy, is reportedly the most common long-term complication after CM surgery in children with an incidence of 13–20% recorded, the risk being particularly high in type IV CMs125,130. Especially when recurrent cholangitis or hepatolithiasis occurs after CM surgery, a biliary-enteric anastomotic stricture should be ruled out with magnetic resonance cholangiopancreatography (MRCP). A verified anastomotic stricture is primarily managed with endoscopic or transhepatic balloon dilation with a high success rate, while reoperation on is considered as a secondary option131. Tsuchida et al.132 described variant types of intrahepatic bile duct (IHD) anatomy associated with postoperative intrahepatic cholelithiasis. In their study, these were classified into three types, i.e. type I, no IHD dilation; type II, IHD dilation without downstream stenosis; and type III, dilatation of IHD with downstream stenosis. Intrahepatic cholelithiasis developed only in 1% of patients who had types I and II IHD dilatation. In contrast, for type III IHD dilatation the occurrence was as high as 40%. The reported time interval after surgery to the development of intrahepatic stone disease ranges anywhere between a few years to several decades.

The risk of biliary malignancy in adult patients with CM ranges from 6 to 30% with typical age of presentation at 45–51 years125,133–135. According to a recent meta-analysis, 1.8% of patients with CM type I or type IV developed malignant transformation after complete cyst excision136. The reasons for the malignant transformation following cyst excision are unclear and it may develop anywhere in the remaining parts of the biliary tree. Biliary dysplasia is found in some 15% of resected CM specimens, while postoperative MRCP may demonstrate an excessive distal remnant of the common bile duct in occasional patients mandating intensified follow-up or excisional surgery120,134,137. Incomplete excision of the distal cyst or PBM may also lead to protein plug formation and postoperative pancreatitis, which is a rare complication125. In addition to postoperative adhesive obstruction and volvulus, other possible factors of intestinal morbidity rate linked to CMs include stricture of the enteroanastomosis, retrograde intestinal intussusception as well as inflammatory bowel disease137,138.

Patients operated on for CM in childhood are at risk of developing cholangitis, stricture of the biliary-enteric anastomosis, hepatolithiasis and biliary malignancies. As the fate of these potential long-term complications remains currently unclear, based on the current evidence different authors and institutions are increasingly committed to structured follow-up programmes, which continue beyond childhood with transition to adult care125,139. Nevertheless, as with many of the conditions discussed in this review, transitional care models and adult follow-up programmes remain in their infancy. Few recommendations have been published to date140,141.

Biliary atresia

Biliary atresia (BA) is a congenital disease characterized by progressive fibrosclerosing obliterative cholangiopathy. It is the leading cause of obstructive jaundice in neonates and the most common indication for liver transplantation in children worldwide142. The prevalence of BA varies by geographic region and race with an incidence of 1 in 5000 to 8000 live births in Asia and around 1 in 14 000 to 19 000 live births in Western countries143. The underlying reason for the discrepancy may be due to differences in population genetics and predisposition to environmental factors between the East and West. Several candidate genes, such as ADD3 and GPC1, have been shown to associate with BA144. A viral trigger causing biliary obstruction in utero has long been considered a possible aetiological factor. Viruses implicated in BA include cytomegalovirus (CMV), reovirus and rotavirus. CMV is the most frequently analysed virus with a possible connection to poor surgical outcome145. Furthermore, as BA patients exhibit a dominant Th1 immune response, and other studies have demonstrated a decrease in frequency and function of T regulatory cells (Tregs), immune dysregulation seems an important factor in the pathogenesis of BA146,147. BA can be categorized into several clinical subtypes: isolated BA (IBA), syndromic BA (SBA), cystic BA (CBA) and cytomegalovirus-associated BA (CMVBA), reflecting aetiological heterogeneity of the disease148. It can also be categorized according to the level of the most proximal obstruction (Fig. 7)142.

Fig. 7 Schematic illustration of the three major subtypes of biliary atresia (adapted from Hartley et al.142)

For the diagnosis of BA, intraoperative cholangiography remains the ‘standard’. Once confirmed, Kasai portoenterostomy (KPE) is performed to restore adequate biliary drainage. KPE was first described by Morio Kasai in 1959 with the excision and transection of the obliterated extrahepatic bile ducts at the level of the portal plate, followed by drainage of remnant microscopic bile ductules using a Roux-loop (Fig. 8)149. Despite this revolutionary procedure, the resolution rate of cholestasis and long-term native liver survival remain suboptimal, and most patients still require liver transplantation before reaching adulthood150–155. In patients who present late with advanced cirrhosis, primary liver transplant without prior KPE is considered the best treatment option.

Fig. 8 The Kasai portoenterostomy

After excision of the extrahepatic biliary tree, the porta hepatis is transected to expose the remaining microscopic ductules and a jejunal Roux limb is anastomosed to the transected surface.

Clinical outcome after KPE remains difficult to predict due to disease heterogeneity and contribution of multiple clinical variables. The age at KPE has long been identified as one of the main factors predicting the likelihood of resolution of cholestasis. As the KPE performed before 60 days of life has been shown to improve native liver survival, early diagnosis and treatment is vital. Patients who fail to normalize their serum bilirubin by 3 months after KPE are likely to require liver transplantation by the age of 2 years156,157. Individual centres’ expertise and BA subtype also impact patient outcome158. Patients with evidence of CMV infection may have poorer KPE outcomes and some centres now administer antiviral therapy for this specific group of patients159,160. After surgery, the use of steroids is widely adopted for its anti-inflammatory effect and promotion of bile flow. A recent RCT and meta-analysis both confirmed that postoperative adjuvant steroid therapy improved bile drainage and native liver survival161,162. Recurrent cholangitis is another significant factor which negatively affects native liver survival. Thus, post-KPE patients who present with fever and cholangitis should be promptly treated with antibiotics163,164.

Management following KPE includes prevention and treatment of chronic liver disease complications and optimization of nutrition and growth. Failure to establish adequate bile flow after KPE leading to rapidly progressing liver failure, intractable cholangitis and growth failure are common indications of early liver transplantation post-KPE. Overall, about half of BA patients after KPE require a liver transplant by 2 years of age. The outcome of BA patients after liver transplantation is generally excellent, with graft and patient survival reaching 90 and 97% respectively165.

Patients who continue to survive with their native liver require lifelong follow-up. Eventually most of these patients develop complications of chronic cholangiopathy, including cirrhosis, portal hypertension with oesophageal varices, and recurrent cholangitis150,166. As well as these liver-related problems, native liver survivors are predisposed to impaired bone health, neurodevelopmental problems and reduced QoL166. BA patients with disease complications report a significantly lower vitality score than those without167. Similar findings were found in a recent systematic review summarizing nine QoL studies168. For female survivors who reach adulthood, pregnancy has been associated with serious complications169. Transition for BA patients from paediatric to adult services may be challenging. Adult health professionals may have limited experience with the condition-specific potential complications, both medical and psychosocial. For example, adult liver disease scoring systems are not optimal tools to predict the need for liver transplantation in adult BA patients170. Setting up multidisciplinary transition clinics attended by both paediatric and adult professionals promotes continuation of efficient patient care141. Nonetheless, as before, transitional care models and adult follow-up programmes remain in their infancy. Few recommendations have been published to date but this is an evolving area of research interest140.

Colorectal

Hirschsprung disease

Hirschsprung disease (HSCR) is a congenital condition in which neural crest-derived cells fail to complete their rostrocaudal migration along the length of the intestine, leaving the distal bowel devoid of ganglion cells171. The length of aganglionosis is variable, with 75% of cases limited to the rectosigmoid (referred to as short-segment HSCR), approximately 8% having total colonic aganglionosis and 1% exhibiting total intestinal aganglionosis172. HSCR affects 1 in 5000 births, with a male-to-female ratio of 4:1, and 8% having Down syndrome173. HSCR is a polygenic disorder with variable inheritance patterns and rearranged during transfection (RET) mutations being the most common genetic aetiology173. Most cases present in neonates, with failure to pass meconium within the first 48 h of life. This, often combined with abdominal distension, emesis and feeding difficulty, prompts a contrast enema that may show the classic finding of a narrowed rectum with proximal colonic dilatation. The ‘standard’ for diagnosis is a rectal biopsy, typically done at the bedside, which will show the absence of ganglion cells, loss of calretinin immunostaining and the presence of hypertrophic nerve fibres171,173.

Once the diagnosis is made, rectal irrigations are initiated to evacuate stool and thereby decompress the colon173,174. For short-segment HSCR, definitive pull-through surgery is typically performed within the first few months of life. In children with more extensive aganglionosis, irrigations are often ineffective and a diverting ostomy is required. In these cases, stoma reversal and pull-through surgery are timed individually171,172.

The fundamental principle of operative treatment for HSCR is to bring normally ganglionated bowel to the anus. The most common operations performed include the Swenson, Yancey-Soave and Duhamel procedures (Fig. 9)175, each of which is an effective approach, the choice largely depending on the surgeon’s preference171,173. In the Yancey-Soave pull-through, the muscular wall of the aganglionic rectum is left in place, and the more proximal ganglionated bowel is pulled through this muscular cuff and anastomosed to the anus. This is done to avoid dissection around the rectum and injury to the pelvic innervation. This operation is commonly performed transanally with laparoscopic assistance both to obtain frozen section biopsies of the bowel and to help with mobilization of the colon and division of the mesentery. In contrast to an endorectal pull-through, the Swenson procedure involves a full-thickness dissection of the rectum down to the anal canal. Another common operation for HSCR is the Duhamel procedure, in which a retrorectal dissection is performed and the distal aganglionic rectum is preserved. The proximal ganglionated bowel is brought down behind the rectum and a side-to-side anastomosis performed, thereby creating a neorectum that can function as a reservoir for stool and which is composed of normally innervated bowel posteriorly and aganglionic rectum anteriorly. In each of these operations, it is important to obtain intraoperative biopsies for frozen section analysis of the proximal margins to confirm that all the aganglionic bowel is removed. In addition, the transition zone, which refers to the hypoganglionic segment between the aganglionic and normal bowel, also needs to be excised and removed, which is why an additional 5–10 cm of bowel is resected proximal to the biopsy confirming the presence of ganglion cells171. Patients with total or near total intestinal aganglionosis are managed with end-jejunostomy and permanent parenteral nutrition, which may necessitate intestinal transplantation later in life176.

Fig. 9 Schematic illustration of the three common operations for Hirschsprung disease—Yancey-Soave, Swenson and Duhamel procedures

N.B. ‘+’ symbol denotes the presence of ganglion cells; ‘–’ symbol indicates absence of ganglion cells. Adapted from Dasgupta and Langer175.

Despite removal of the aganglionic segment, children with HSCR are at risk of long-term complications following surgery171,173,177. These include impaired faecal control, obstructive bowel symptoms and Hirschsprung-associated enterocolitis (HAEC). The reasons for these are not entirely known, but a multitude of factors have been proposed, including abnormal motility of the remaining bowel, non-relaxing anal sphincters, dysbiosis, iatrogenic injury to pelvic innervation or anal sphincters, and functional constipation171,173,177,178.

HAEC is the most common cause of death in HSCR. It is an inflammatory condition that is associated with obstructive symptoms and presents with foul-smelling diarrhoea, abdominal distention, vomiting and fever, sometimes progressing to sepsis171,173,178. Its aetiology is unknown, but appears to be multifactorial, including abnormalities within the enteric immune system, epithelial barrier integrity and intestinal microbiome171,173. HAEC can occur before or after definitive surgery for HSCR and its reported incidence is highly variable, ranging from 10 to 40%, due to lack of a clear definition or any diagnostic clinical markers. Treatment for mild cases includes rectal irrigations and oral metronidazole, while more serious cases require inpatient management with intravenous fluids, broad-spectrum antibiotics and rectal irrigations. Diverting ileostomy can be lifesaving for severe, refractory HAEC. Fortunately, HAEC most often stops occurring by the time a child reaches school age179.

Obstructive symptoms refer to severe difficulty evacuating, usually with concomitant abdominal distension150,178. This is relatively common, occurring in up to 33% of patients, and can persist into adolescence and adulthood177. Multiple causative factors have been identified, including: mechanical obstruction of the bowel due to anastomotic stricture, twisting of the pull-through, a tight muscular cuff following a Yancey-Soave endorectal pull-through or rectal spur after a Duhamel pull-through; internal anal sphincter achalasia, since the normal recto-anal inhibitory reflex is absent in HSCR, even after pull-through surgery; a transition zone pull-through, in which the abnormally innervated transition zone is not removed; colonic dysmotility due to abnormal enteric neurons even in the seemingly normal ganglionated bowel; and functional constipation, in which children develop withholding behaviour due to a history of anal surgery and painful defaecation171,173,178,180. The evaluation of a patient with obstructive symptoms can include anorectal examination, contrast enema, repeat rectal biopsy, anorectal manometry and colonic manometry, with the evaluation tailored to the case. It is very important to establish the cause so that a targeted treatment strategy can be initiated180.

Faecal soiling (escape of small amounts of liquid or soft stool) is a common long-term complication, affecting up to 50% of adult patients after surgery for HSCR172,181. Soiling is often associated with an increased defaecation frequency due to active peristalsis in the pulled through bowel and the absence of a normal rectum to serve as a reservoir for stool, often also with the inability to feel the urge to defaecate177,178. True incontinence, with inability to hold back defaecation, is due to abnormal anorectal sensory function or inadequate sphincter control, and is treated with bowel management, including retrograde or antegrade enemas, or a diverting ostomy182. In contrast, patients with faecal impaction with resulting overflow incontinence should be considered in the category of obstructive symptoms and therefore the evaluation should be as described above178,179,182. While faecal control usually improves with age, especially around adolescence179,183, variable degrees of faecal incontinence or constipation, depending on the type of pull-through, persist into adolescence and adulthood in 30–50% of patients177,179,183,184. This has a significant impact on QoL as diminished faecal control correlates highly with social, emotional and sexual wellbeing183,185,186. Interestingly, while bowel function often improves with time, some aspects of QoL may not, possibly reflecting residual psychological burden from childhood185.

Although rectal dissection predisposes to iatrogenic pelvic injuries, lower urinary tract and erectile function appear well preserved in the majority of adult HSCR patients186–188. However, adult female patients not only reported decreased sexual QoL, but also difficulties conceiving spontaneously, possibly related to postoperative pelvic adhesions188. Another increasingly recognized and poorly understood long-term complication of HSCR is inflammatory bowel disease. In a Swedish national study, the risk of inflammatory bowel disease, mostly classified as Crohn’s disease, was about five-fold higher than in the general population189. Some rare RET mutations causing HSCR may also give rise to familial medullary thyroid carcinoma, which usually manifests in adulthood190.

Transitional care pathways and adult care programmes for congenital anorectal disorders are not widely adopted174,191,192. The authors are not aware of specific adult guidelines for patients with Hirschsprung disease; however, the ERNICA guidelines for the management of rectosigmoid Hirschsprung disease do include recommendations for adult follow-up171.

Anorectal malformations

Anorectal malformations are amongst the most common congenital anomalies of the gastrointestinal tract diagnosed in approximately 1 in 3000 live births. They display extremely heterogenous phenotypes ranging from a slightly malpositioned anus to complex anomalies involving the anorectum, urethra and genitalia193. Aetiology is multifactorial without a clearly established genetic background despite occasional association with chromosomal defects and known syndromes. Anorectal malformations arise early in fetal development as a result of disrupted division of the primitive cloaca, leading to impaired separation of the genitourinary tract and bowel194. Over 65% of patients have associated anomalies mostly involving the spine, spinal cord, kidneys and other parts of the intestine193. The clinical diagnosis is usually apparent immediately after birth due to inability to pass meconium and absence of a normal anal opening in the perineum. In occasional patients with mild malformations the diagnosis may be delayed and is made based on constipation or obstructive symptoms. Anorectal malformations can be classified simply as low or high, but the anatomic abnormality may be more accurately described according to the widely used Krickenbeck classification system (Table 1195 and Fig. 10).

Fig. 10 Male newborn with a high anorectal malformation

Note absence of anal orifice and flattened buttocks.

Table 1 Major clinical groups of anorectal malformations (Krickenbeck classification)195

Perineal fistula	
Rectourethral fistula	
 Prostatic
 Bulbar
Rectovesical fistula
Vestibular fistula
Cloaca
No fistula
Anal stenosis	

In general, the surgical treatment is dictated by the level at which the rectum terminates. Patients with a perineal or vestibular fistula can be operated on primarily as newborns or infants. If the anal opening is stenotic but surrounded by the external sphincter muscle, they may be amenable to dilatations or simple anoplasty only. Others may receive a diverting colostomy within 48 h and undergo reconstructive surgery several months later after detailed assessment of the type and anatomy of the malformation and associated anomalies. Operative treatment is mainly based on posterior sagittal anorectoplasty (PSARP; pioneered by Alberto Peña), or less popularly, by anterior sagittal anorectoplasty (ASARP), both of which allow the precise separation and correct relocation of the rectum including reconstruction of the neoanus with the external sphincter muscles under direct vision196. The use of an intraoperative muscle stimulator is indispensable. A high-lying rectum opening into the prostatic urethra, bladder neck or vagina may require combined transabdominal laparoscopic or open mobilization. Particularly challenging are female cloacal malformations where rectum, vagina and urethra open into a common channel, which exits in the perineum through a single orifice. In some patients with a long common channel (>3 cm), the vagina may not reach the perineum without additional reconstructions such as sigmoid- or ileo-vaginoplasty.

Depending on the severity of the malformation, patients experience variable degrees of long-term morbidity rates in bowel and genitourinary function, and are at risk of decreased sexual health, fertility and QoL197. Functional defects may arise secondary to the combined effects of congenital hypoplastic pelvic sphincter musculature, disordered pelvic innervation, sacral hypoplasia, spinal malformations and surgical injury193,197.

While the majority of patients with milder malformations achieve faecal continence, most patients with more severe malformations suffer from deficient faecal control such that assurance of social continence requires active bowel management with regular rectal washouts or antegrade colonic enemas through an appendicostomy or cecostomy193,197. Regardless of the severity of the malformation, constipation is common and continues into adulthood in a proportion of patients, necessitating regular laxative treatment and in some cases, bowel management programmes197. While social constraints and decreased QoL are rare findings in patients with mild malformations, social disability affects a considerable portion of patients, with the more severe anorectal malformations having impaired long-term faecal continence outcomes185,197.

Bladder function and urinary continence are usually well preserved and comparable to normal population controls in patients with milder malformations187,198. In more complex anorectal malformations, however, prevalence of neurogenic bladder dysfunction and accompanying urinary incontinence is higher and may be permanent in the most severe cases. These patients may empty their bladder with clean intermittent catheterization or through a continent vesicostomy. Permanent urinary incontinence is most common in female patients operated on for cloacal malformations199. Associated congenital malformations of the kidneys together with bladder dysfunction and recurrent urinary tract infections may rarely lead to renal insufficiency.

Genital abnormalities are more common in girls, including duplication and agenesis of the vagina and uterus, most frequently encountered in cloacal malformations200. A gynaecological examination is considered essential at the time of puberty to ensure unobstructed menstruation and anatomical capacity for sexual intercourse. Vaginal septation and introital stenosis are typical concerns requiring additional interventions at this time point. Dyspareunia, possibly due to vaginal scarring, is a common concern and sexual dysfunction may affect up to 50% of females198,200. The majority of women operated on for anorectal malformations can conceive and carry a pregnancy200,201. Elective caesarian section, unlike vaginal delivery, avoids the risk of anal sphincter injury and is possibly the safest delivery mode at least for women with operated on cloacal malformation200. Erectile dysfunction and retrograde ejaculation may occur in 10–20% of males, especially in association with complex malformations and those with significant sacral dysplasia198.

Patients with HSCR and anorectal malformations therefore require continuous structured healthcare follow-up and support throughout childhood and beyond as functional problems can persist well into adulthood and correlate with social disability and decreased QoL174. Patients who continue to experience significant psychosocial limitations in the long term highlight the crucial need for robust transitional care arrangements197. There is no doubt that additional longitudinal studies are needed, particularly focused on identifying optimal long-term therapeutic and management strategies. Most importantly, wide interdisciplinary collaboration between paediatric and adult colorectal surgeons, gastroenterologists and other pertinent healthcare professionals is essential as these patients transition into adulthood. As mentioned in the previous section, transitional care pathways for anorectal disorders are not widely adopted, and more so, adult care programmes174,191,192. The authors are not aware of adult guidelines for patients with anorectal malformations.

Thoracic

Congenital lung malformations

Congenital lung malformations (CLMs) encompass a wide spectrum of developmental disorders. These include congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS), bronchial atresia, bronchogenic cysts (BCs) and congenital lobar overinflation (CLO) (Fig. 11202). Lung lesions were once thought to be very rare, but with recent advances in antenatal diagnosis, the incidence of CPAM, for example, has risen to as high as 1:7200 live births203. These abnormalities arise as a result of aberrant organogenesis and dysregulation in epithelial–mesenchymal interaction at various time points during early human lung development204. CPAM is the commonest CLM with the lesion in direct communication with adjacent lung parenchyma (Fig. 12). It is characterized by proliferation of bronchial structures rather than alveoli. BPS refers to a mass of lung tissue not in continuity with the tracheobronchial tree with an aberrant systemic arterial supply as its key hallmark. On the other hand, CLO is an overinflation of a pulmonary lobe caused by air trapping from bronchial narrowing. In bronchial atresia, there is focal obliteration of a proximal bronchial segment. The lung distal to this becomes overinflated and the bronchi distal to the atresia may appear as a mucocoele on cross-sectional imaging. BC is a unilocular malformation mostly found in the mediastinum adjacent to the trachea or the mainstem bronchi with no direct communication to the tracheobronchial tree.

Fig. 11 Illustrations of common subtypes of congenital lung lesions

Adapted from Doktor et al.202.

Fig. 12 Transverse CT image showing a right lower lobar congenital pulmonary airway malformation (CPAM)

Whilst the majority of CLM are now diagnosed early in gestation205, they mostly cause no detrimental effect, with the fetus often delivered at full term. However, if these lesions are very large they may cause external compression to surrounding structures, leading to pulmonary hypoplasia or hydrops fetalis. The CPAM volume ratio (CVR) is now accepted as an important prognostic index of neonatal outcome in prenatally diagnosed CPAMs206. In ‘high-risk’ fetuses with hydrops from large CLM, fetal intervention may be considered. This carries risks of premature delivery and fetal death so parents need to be counselled extensively prior to undertaking fetal surgery207. Alternatively and more recently, expedient caesarean section may now be scheduled in specific high-risk fetal cases with emergent postnatal lung lesion resection performed thereafter (‘section-to-resection’) as the preferred strategy option in specialist centres208.

After delivery, 90% of babies with CLM are generally asymptomatic, but some may have respiratory distress due to the mass effect of the lesion with mediastinal shift. There is no argument that symptomatic patients will require early/emergency surgery to alleviate symptoms. For asymptomatic patients, there is an unresolved controversy amongst paediatric surgeons about best practice management, currently the subject of an international randomized trial, and also a prospective patient registry209,210. Many surgeons worldwide are nonetheless still in favour of prophylactic surgical resection of asymptomatic cases of CPAM, as the key argument for surgery is to prevent future risks of complications, notably recurrent chest infections and malignant transformation211–213. To the contrary, some clinicians remain unconvinced of potential risks and consider conservative management with regular follow-up an alternative approach211–216. The arguments for a conservative approach centre not only around an overestimation of potential sequelae for the untreated CPAM but also the avoidance of surgery and general anaesthesia in otherwise healthy newborns.

Thoracoscopic lobectomy in children with CLM is considered the standard of care for all its known advantages where feasible217,218. Comparing with video-assisted thoracoscopic surgery in adults, thoracoscopic lobectomy in newborns and small infants may only require a single 5 mm and two 3 mm trocars. Recently published data suggest resection of CPAM at a younger age is generally associated with better perioperative outcomes217,219.

For patients who have undergone thoracoscopic lobectomy, future risks of recurrent infections and malignancy should be largely eliminated. In terms of parental concerns about lung function after resection of a single lobe, there appears not to be any measurable deficit in mid-term outcomes220. Minimally invasive surgical techniques also have more favourable outcomes in offsetting the risk of developing musculoskeletal deformity221. In terms of daily activities, exercise capacity for CPAM patients who underwent resection in early life was found to be comparable to healthy controls220.

On the other hand, for those patients who are managed non-operatively or undergo a ‘watchful waiting’ policy, the main argument for the need for long-term follow-up is that some children will go on to later develop symptoms of which the most concerning are risks of malignancy, although this metric remains poorly defined. Recent research has shed some light on the association between CPAM and tumours showing the presence of Kirsten rat sarcoma virus (KRAS) gene mutations (one of the most frequently mutated genes in lung cancer) in mucinous and non-mucinous cells of CPAMs type 1222,223. Conservative management is typified by structured, regular outpatient visits. Given that most asymptomatic lesions do not significantly change, nor do they appear readily visible on plain chest X-ray, the use of this modality planning is doubtful. CT scan surveillance will certainly provide definitive detailed information but there is a concern of subjecting young children to excessive radiation dosage from repeated CT imaging. Magnetic resonance imaging negates this risk, but is a more limited resource and in childhood often requires general anaesthesia. When these non-operated children reach adulthood the vexing questions that adult surgeons frequently have relate to the length and absolute necessity of long-term follow-up. There have indeed been isolated case reports of lung adenocarcinoma arising from CPAM in adult patients224–227. Overall, current literature on long-term outcomes in CLM patients remains scarce, but taking the potential morbidity rate of recurrent respiratory infections, reduced exercise tolerance and risk of malignancies later in life into account, patients should ideally be followed up by specialists in dedicated centres to ensure smooth transitional care into adulthood. With a lack of consensus in best practice management of CLM in childhood, the authors are not aware of any specific or robust recommendations published for the transitional care or adult follow-up of these patients.

Congenital diaphragmatic hernia

CDH occurs in 1:2500 births with a baby born approximately every day in the UK (Fig. 13)228. A defect in closure of the developing diaphragm allows abdominal viscera including liver and spleen to herniate into the thorax, negatively impacting lung development. A primary lung insult involving primordial growth is also postulated, giving rise to the now widely accepted ‘Two Hit Hypothesis’229,230. CDH carries an appreciably high mortality rate (more than 50%), with the resultant lung hypoplasia and pulmonary hypertension arising from disorganized airway and aberrant vasculature biology. Urgent operative intervention by means of hernia repair was once surgical dogma; however, over recent decades, elective delivery scheduled at specialist centres following in utero diagnosis with stabilization of labile cardiopulmonary physiology and delayed operation is nowadays considered paramount to achieve better survival outcomes231,232. The operation involves primary native diaphragm repair or securing prosthetic patch closure dependent on defect size (Fig. 14)233,234. Classical open repair and minimally invasive techniques are deployed with a growing recognition that not all newborns with a CDH are suitable for thoracoscopy, which is best reserved for smaller diaphragmatic defects in low-risk patients, given higher recurrences in larger defects234–236. Fetal risk prognostication according to observed to expected lung-head ratio (O/E LHR) and liver herniation has guided and driven the development of fetal surgery RCTs (the tracheal occlusion to accelerate lung growth (TOTAL) trials) with fetoscopic endoluminal tracheal occlusion (FETO) offered at designated specialist fetal medicine centres in an effort to rescue and stimulate prenatal lung growth237–239. Permissive hypercapnia, better termed ‘gentle ventilation’, together with extracorporeal membrane oxygenation (ECMO) have seen CDH survival outcomes (more than 75%) improve at many institutions, such that fetal intervention, at time of writing, is considered controversial and the subject of ongoing debate240.

Fig. 13 Plain radiograph of a newborn with left congenital diaphragmatic hernia (CDH)

Note intestinal viscerae herniated into left hemithorax.

Fig. 14 Congenital diaphragmatic hernia (CDH) study group classification system popular for grading severity of diaphragmatic hernia

a Small defect amenable to primary closure; b and c moderate defects which may require patch repair; d diaphragmatic agenesis mandates patch closure. Adapted from Lally et al.233.

CDH survivors require lifelong follow-up best coordinated through multidisciplinary clinics led by paediatric surgeons with respiratory physicians, cardiologists and allied healthcare professionals with transition to adult hospital services considered essential as adolescent years advance241–243. Health outcomes and QoL are crucially interlinked to several multiple organ systems which include pulmonary, cardiac, gastrointestinal/nutritional, orthopaedic, neurocognitive and executive functioning241–244. Hernia recurrence with reoperation on can occur at any age in aftercare follow-up. GORD in newborns, infancy or childhood requiring fundoplication with or without feeding gastrostomy is not uncommon. Pectus chest wall deformity or scoliosis needing surgical correction or use of bracing appliances can also be problematic secondary to open surgery or patch use243. Lung function abnormalities characterized by ventilation-perfusion mismatch involves respiratory medicine aftercare surveillance whilst pulmonary hypertension and cardiac disease mandates a structured healthcare follow-up plan241–246. Advocacy and charitable support groups such as CDH UK and CDH International are a vital network portal for many patients and families worldwide from initial antenatal diagnosis extending well beyond into adulthood247. Whilst there is a growing interest in the long-term impact of CDH in adult survivors, the authors are not aware of any specific recommendations for transitional care, nor adult care programmes248.

Cancer

Cancer is the second leading cause of death after trauma in the paediatric age group249. Unlike many adult cancers integrally linked to risk lifestyle such as smoking and excess alcohol consumption, paediatric solid tumours often have a developmental biology or genetic component as their basis. Remarkable advances in survival have occurred in recent decades with multimodal cancer therapies. Childhood solid tumour malignancies such as Wilm’s tumour and neuroblastoma have 5-year survival rates now approaching 92 and 60% respectively250–252. Success steadily continues with many other solid tumours, notably germ cell tumours and sarcomas, whilst other rare tumours such as aggressive primitive neuroectodermal neoplasms as a key noteworthy example may have variably poor outcomes, with less than 40% survival despite current therapies253–257. The defining role of surgery in the curative treatment of many childhood tumours links with individual patient risk staging categorization and biology. Organ-sparing surgery is now steadily applicable to certain Wilm’s tumour (that is ‘nephron-sparing’ operations), benign ovarian and testicular neoplasms, all in a concerted effort to offset consequences of late-onset hyperperfusion-induced renal failure in the formerly nephrectomized patient with a remaining solitary healthy kidney and the lifetime risk of infertility in those harbouring gonadal tumours258–262. Surveillance of the long-term effects related to treatment of childhood cancer includes actively monitoring risk of tumour recurrence, metachronous tumour, second late ‘new malignancies’, for example thyroid cancers resultant from earlier primary cancer therapies, chest wall or spinal deformity (Fig. 15), growth impairment, functional sequelae and sterility249,263–265. Late effects of cancer management in childhood therefore extend into adulthood. For patients with inherited polyposis disorders, such as Peutz–Jeghers syndrome, and family cancer predisposition syndromes, such as Li-Fraumeni syndrome, lifelong follow-up is also critical as multiple new tumours invariably occur in these vulnerable high-risk individuals266,267. Functional sequelae resulting from childhood cancer surgery are currently being investigated in an international multicentre collaborative study (FUSE (Functional Sequelae Assessment In Pediatric Surgical Oncology)) led by St Jude Children’s Research Hospital Memphis, USA, and the International Society of Paediatric Surgical Oncology. Transition to adult cancer services is therefore key and essential for long-term follow-up, active monitoring of survivorship health and crucially maintaining QoL268.

Fig. 15 Scoliosis which has developed after chest wall tumour resection

PA, posteroanterior; L, left.

Future directions

Over the past few decades, the focus of many surgical conditions of childhood has evolved from a desire to achieve high rates of survival, to understanding the impact on the child and their family, and minimizing the lifelong implications of the pathology and its treatment. With this shift in focus, we will eventually better understand the natural history of some of these conditions (for example congenital lung lesions and biliary atresia), the optimal surgical strategies for affected children (for example Hirschsprung disease and oesophageal atresia) and reduce the long-term morbidity rate from treatment (for example paediatric solid tumours and minimally invasive surgery (MIS) techniques). Historically, high-quality research has been limited by the challenge of consent in patients who often lack capacity, ethical concerns and the rarity of conditions, limiting the volume of single-centre experiences269. Routine collection of better data in healthcare, development of core outcome sets, creation of prospective registries, multicentre trials, more translational research and better international collaboration through the development of networks (such as the European Reference Networks in continental Europe), will offer opportunities to achieve these aims. In addition, the increasing survivorship of children affected by surgical conditions will translate into a growing population of adults with lifelong conditions and specialist healthcare needs. The importance of transition from childhood to adulthood is becoming realized270. These programmes are currently sparse and in their infancy, but routine transition of care, anticipatory planning and structured follow-up for conditions with lifelong implications need to be developed and made available. Not only do the conditions discussed in this review affect physical health, they carry a psychosocial burden which must be considered by healthcare professionals during long-term follow-up. Studies of adult survivors so far have focused on clinical outcomes, but there is a need and desire for more study and reporting of outcomes most important to patients. Research focusing on the subtleties missed by QoL measurement tools are warranted, to include impact on mental, social, sexual, educational and occupational aspects of wellbeing271–274. Furthermore, another key issue that adolescent and young adult patients experience is a lack of familiarity of adult healthcare professionals with rare congenital conditions. Currently, patient support groups remain a useful source of information, provide advocacy and allow those affected by surgical conditions of childhood to network with others (for example TOFS, CDH UK, Reach and Max’s Trust). Patients, however, crucially need adult clinicians to develop interest and expertise in managing surgical conditions of childhood. We hope that the reader finds this article a helpful summary of these rare diseases and their long-term impact for adult surgeons, and that some are inspired to care for these unique, grown-up children.

Funding

The authors have no funding to declare.

Author contributions

Paul Cullis (Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing—original draft, Writing—review & editing), Dina Fouad (Methodology, Writing—original draft, Writing—review & editing), Allan Goldstein (Methodology, Visualization, Writing—original draft, Writing—review & editing), Kenneth Kak Yuen Wong (Visualization, Writing—original draft, Writing—review & editing), Ampaipan Boonthai (Writing—original draft), Pablo Lobos (Visualization, Writing—original draft), Mikko Pakarinen (Data curation, Methodology, Supervision, Visualization, Writing—original draft, Writing—review & editing), and Paul Losty (Conceptualization, Data curation, Methodology, Supervision, Visualization, Writing—original draft, Writing—review & editing)

Disclosure

The authors declare no conflict of interest.

Data availability

This article is based on published literature as a narrative review and therefore there are no data to share separately.
==== Refs
References

1 Blum  RW, Garell  D, Hodgman  CH, Jorissen  TW, Okinow  NA, Orr  DP  et al  Transition from child-centered to adult health-care systems for adolescents with chronic conditions. J Adolesc Health  1993;14 :570–576 8312295
2 Campbell  F, Biggs  K, Aldiss  SK, O’Neill  PM, Clowes  M, McDonagh  J  et al  Transition of care for adolescents from paediatric services to adult health services. Cochrane Database Syst Rev  2016;4 :CD009794 27128768
3 Page  MJ, McKenzie  JE, Bossuyt  PM, Boutron  I, Hoffmann  TC, Mulrow  CD  et al  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ  2021;372 :n71 33782057
4 Nassar  N, Leoncini  E, Amar  E, Arteaga-Vázquez  J, Bakker  MK, Bower  C  et al  Prevalence of esophageal atresia among 18 international birth defects surveillance programs. Birth Defects Res A Clin Mol Teratol  2012;94 :893–899 22945024
5 Pedersen  RN, Calzolari  E, Husby  S, Garne  E, EUROCAT Working Group. Oesophageal atresia: prevalence, prenatal diagnosis and associated anomalies in 23 European regions. Arch Dis Child  2012;97 :227–232 22247246
6 Rintala  RJ, Sistonen  S, Pakarinen  MP. Outcome of esophageal atresia beyond childhood. Semin Pediatr Surg  2009;18 :50–56 19103423
7 van Lennep  M, Singendonk  MMJ, Dall’Oglio  L, Gottrand  F, Krishnan  U, Terheggen-Lagro  SWJ  et al  Oesophageal atresia. Nat Rev Dis Primers  2019;5 :26 31000707
8 Lemoine  C, Aspirot  A, Le Henaff  G, Piloquet  H, Lévesque  D, Faure  C. Characterization of esophageal motility following esophageal atresia repair using high-resolution esophageal manometry. J Pediatr Gastroenterol Nutr  2013;56 :609–614 23343933
9 Connor  MJ, Springford  LR, Kapetanakis  VV, Giuliani  S. Esophageal atresia and transitional care—step 1: a systematic review and meta-analysis of the literature to define the prevalence of chronic long-term problems. Am J Surg  2015;209 :747–759 25605033
10 Koivusalo  A, Pakarinen  MP, Rintala  RJ. The cumulative incidence of significant gastrooesophageal reflux in patients with oesophageal atresia with a distal fistula—a systematic clinical, pH-metric, and endoscopic follow-up study. J Pediatr Surg  2007;42 :370–374 17270551
11 Comella  A, Tanny  T, Hutson  SP, Omari  JM, Teague  TI, Nataraja  WJ  et al  Esophageal morbidity in patients following repair of esophageal atresia: a systematic review. J Pediatr Surg  2021;56 :1555–1563 33051081
12 Khlevner  J, Jodorkovsky  D, Bailey  DD, Middlesworth  W, Sethi  A, Abrams  J  et al  Management of adults with esophageal atresia. Clin Gastroenterol Hepatol  2023;21 :15–25 35952943
13 Rintala  RJ . Fundoplication in patients with esophageal atresia: patient selection, indications, and outcomes. Front Pediatr  2017;5 :109 28555181
14 Sistonen  SJ, Koivusalo  A, Lindahl  H, Pukkala  E, Rintala  RJ, Pakarinen  MP. Cancer after repair of esophageal atresia: population-based long-term follow-up. J Pediatr Surg  2008;43 :602–605 18405703
15 Brooks  G, Gazzaneo  M, Bertozzi  M, Riccipetitoni  G, Raffaele  A. Systematic review of long term follow-up and transitional care in adolescents and adults with esophageal atresia—why is transitional care mandatory?  Eur J Pediatr  2023;182 :2057–2066 36905437
16 Krishnan  U, Mousa  H, Dall’Oglio  L, Homaira  N, Rosen  R, Faure  C  et al  ESPGHAN-NASPGHAN guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with esophageal atresia-tracheoesophageal Fistula. J Pediatr Gastroenterol Nutr  2016;63 :550–570 27579697
17 Weusten  B, Bisschops  R, Coron  E, Dinis-Ribeiro  M, Dumonceau  J-M, Esteban  J-M  et al  Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy  2017;49 :191–198 28122386
18 Fitzgerald  RC, Di Pietro  M, Ragunath  K, Ang  Y, Kang  J-Y, Watson  P  et al  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut  2014;63 :7–42 24165758
19 Qumseya  B, Sultan  S, Bain  P, Jamil  L, Jacobson  B, Anandasabapathy  S  et al  ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointest Endosc  2019;90 :335–359.e2 31439127
20 Shaheen  NJ, Falk  GW, Iyer  PG, Gerson  LB. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol  2016;111 :30–50 26526079
21 Allin  B, Knight  M, Johnson  P, Burge  D; on behalf of BAPS-CASS. Outcomes at one-year post anastomosis from a national cohort of infants with oesophageal atresia. PLoS One  2014;9 :e106149 25153838
22 Raitio  A, Cresner  R, Smith  R, Jones  MO, Losty  PD. Fluoroscopic balloon dilatation for anastomotic strictures in patients with esophageal atresia: a fifteen-year single centre UK experience. J Pediatr Surg  2016;51 :1426–1428 27032608
23 Baird  R, Laberge  J-M, Lévesque  D. Anastomotic stricture after esophageal atresia repair: a critical review of recent literature. Eur J Pediatr Surg  2013;23 :204–213 23720206
24 Lévesque  D, Baird  R, Laberge  J-M. Refractory strictures post-esophageal atresia repair: what are the alternatives?  Dis Esophagus  2013;26 :382–387 23679028
25 Downey  P, Middlesworth  W, Bacchetta  M, Sonett  J. Recurrent and congenital tracheoesophageal fistula in adults. Eur J Cardiothorac Surg  2017;52 :1218–1222 28575191
26 Parolini  F, Morandi  A, Macchini  F, Canazza  L, Torricelli  M, Zanini  A  et al  Esophageal atresia with proximal tracheoesophageal fistula: a missed diagnosis. J Pediatr Surg  2013;48 :e13–e17
27 Mirra  V, Maglione  M, Di Micco  LL, Montella  S, Santamaria  F. Longitudinal follow-up of chronic pulmonary manifestations in esophageal atresia: a clinical algorithm and review of the literature. Pediatr Neonatol  2017;58 :8–15 27328637
28 Losty  PD, Thursfield  RM. Long-term respiratory complications of OA–TOF: the need for better data and a more specialized multidisciplinary approach. Pediatr Pulmonol  2021;56 :317–318 33245202
29 Bastard  F, Bonnard  A, Rousseau  V, Gelas  T, Michaud  L, Irtan  S  et al  Thoracic skeletal anomalies following surgical treatment of esophageal atresia. Lessons from a national cohort. J Pediatr Surg  2018;53 :605–609 28778692
30 Shieh  HF, Jennings  RW. Long-gap esophageal atresia. Semin Pediatr Surg  2017;26 :72–77 28550874
31 Dingemann  C, Eaton  S, Aksnes  G, Bagolan  P, Cross  KM, De Coppi  P  et al  ERNICA consensus conference on the management of patients with long-gap esophageal atresia: perioperative, surgical, and long-term management. Eur J Pediatr Surg  2021;31 :214–225 32668485
32 Krishnan  U, Dumont  MW, Slater  H, Gold  BD, Seguy  D, Bouin  M  et al  The International Network on Oesophageal Atresia (INoEA) consensus guidelines on the transition of patients with oesophageal atresia–tracheoesophageal fistula. Nat Rev Gastroenterol Hepatol  2023;20 :735–755 37286639
33 Adams  SD, Stanton  MP. Malrotation and intestinal atresias. Early Hum Dev  2014;90 :921–925 25448782
34 Strouse  PJ . Disorders of intestinal rotation and fixation (“malrotation”). Pediatr Radiol  2004;34 :837–851 15378215
35 McVay  MR, Kokoska  ER, Jackson  RJ, Smith  SD. The changing spectrum of intestinal malrotation: diagnosis and management. Am J Surg  2007;194 :712–719 18005759
36 Mehall  JR, Chandler  JC, Mehall  RL, Jackson  RJ, Wagner  CW, Smith  SD. Management of typical and atypical intestinal malrotation. J Pediatr Surg  2002;37 :1169–1172 12149695
37 Collins  DC . 71,000 human appendix specimens. A final report, summarizing forty years’ study. Am J Proctol  1963;14 :265–281 14098730
38 Nehra  D, Goldstein  AM. Intestinal malrotation: varied clinical presentation from infancy through adulthood. Surgery  2011;149 :386–393 20719352
39 Neville  JJ, Gallagher  J, Mitra  A, Sheth  H. Adult presentations of congenital midgut malrotation: a systematic review. World J Surg  2020;44 :1771–1778 32030442
40 Graziano  K, Islam  S, Dasgupta  R, Lopez  ME, Austin  M, Chen  LE  et al  Asymptomatic malrotation: diagnosis and surgical management. J Pediatr Surg  2015;50 :1783–1790 26205079
41 Cullis  PS, Siminas  S, Losty  PD. Is screening of intestinal foregut anatomy in heterotaxy patients really necessary? A systematic review in search of the evidence. Ann Surg  2016;264 :1156–1161 26704743
42 El-Gohary  Y, Alagtal  M, Gillick  J. Long-term complications following operative intervention for intestinal malrotation: a 10-year review. Pediatr Surg Int  2010;26 :203–206 19756654
43 Catania  VD, Lauriti  G, Pierro  A, Zani  A. Open versus laparoscopic approach for intestinal malrotation in infants and children: a systematic review and meta-analysis. Pediatr Surg Int  2016;32 :1157–1164 27709290
44 Zhang  Z, Chen  Y, Yan  J. Laparoscopic versus open Ladd’s procedure for intestinal malrotation in infants and children: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech  2022;32 :204–212
45 Martinez  SA, Fligor  SC, Tsikis  S, Short  M, Corcoran  KE, Rogers  A  et al  IMPOWER: a national patient-generated registry for intestinal malrotation exploring diagnosis, treatment, and surgical outcomes. Orphanet J Rare Dis  2023;18 :113 37170358
46 Patel  D, Halverson  C, Jayaraman  M, Ambartsumyan  L, Rodriguez  L. Gastrointestinal symptoms after surgery for intestinal malrotation. J Pediatr Gastroenterol Nutr  2023;77 :316–318 37256844
47 Norsa  L, Goulet  O, Alberti  D, DeKooning  B, Domellöf  M, Haiden  N  et al  Nutrition and intestinal rehabilitation of children with short bowel syndrome: a position paper of the ESPGHAN committee on nutrition. Part 1: from intestinal resection to home discharge. J Pediatr Gastroenterol Nutr  2023;77 :281–297 37256827
48 Duggan  CP, Jaksic  T. Pediatric intestinal failure. N Engl J Med  2017;377 :666–675 28813225
49 Wales  PW, de Silva  N, Kim  J, Lecce  L, To  T, Moore  A. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg  2004;39 :690–695 15137001
50 Puttonen  M, Tuominen  S, Ukkola-Vuoti  L, Lassenius  MI, Virtanen  H, Merras-Salmio  L  et al  Pediatric short bowel syndrome: real-world evidence on incidence and hospital resource use from a Finnish data lake. J Pediatr Gastroenterol Nutr  2023;77 :479  485 37490606
51 Mutanen  A, Engstrand Lilja  H, Wester  T, Norrby  H, Borg  H, Persson  S  et al  A Nordic multicenter study on contemporary outcomes of pediatric short bowel syndrome in 208 patients. Clinical Nutrition  2023;42 :1095–1103 37270343
52 Norsa  L, Goulet  O, Alberti  D, DeKooning  B, Domellöf  M, Haiden  N  et al  Nutrition and intestinal rehabilitation of children with short bowel syndrome: a position paper of the ESPGHAN committee on nutrition. Part 2: long-term follow-up on home parenteral nutrition. J Pediatr Gastroenterol Nutr  2023;77 :298–314 37256821
53 Boroni  G, Parolini  F, Stern  MV, Moglia  C, Alberti  D. Autologous intestinal reconstruction surgery in short bowel syndrome: which, when, and why. Front Nutr  2022;9 :861093 35463997
54 Lambe  C, Talbotec  C, Kapel  N, Barbot-Trystram  L, Brabant  S, Nader  EA  et al  Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome. Am J Clin Nutr  2023;117 :1152–1163 37270289
55 Raghu  VK, Beaumont  JL, Everly  MJ, Venick  RS, Lacaille  F, Mazariegos  GV. Pediatric intestinal transplantation: analysis of the intestinal transplant registry. Pediatr Transplant  2019;23 :e13580 31531934
56 Petit  L-M, Girard  D, Ganousse-Mazeron  S, Talbotec  C, Pigneur  B, Elie  C  et al  Weaning off prognosis factors of home parenteral nutrition for children with primary digestive disease. J Pediatr Gastroenterol Nutr  2016;62 :462–468 26398153
57 Torres  C, Badalyan  V, Mohan  P. Twelve-year outcomes of intestinal failure–associated liver disease in children with short-bowel syndrome: 97% transplant-free survival and 81% enteral autonomy. J Parenter Enteral Nutr  2022;46 :197–206
58 Wendel  D, Mezoff  EA, Raghu  VK, Kinberg  S, Soden  J, Avitzur  Y  et al  Management of central venous access in children with intestinal failure: a position paper from the NASPGHAN intestinal rehabilitation special interest group. J Pediatr Gastroenterol Nutr  2021;72 :474–486 33399327
59 Merras-Salmio  L, Mutanen  A, Ylinen  E, Rintala  R, Koivusalo  A, Pakarinen  MP. Pediatric intestinal failure: the key outcomes for the first 100 patients treated in a national tertiary referral center during 1984–2017. J Parenter Enteral Nutr  2018;42 :1304–1313
60 Khalaf  RT, Sokol  RJ. New insights into intestinal failure–associated liver disease in children. Hepatology  2020;71 :1486–1498 32003009
61 Mutanen  A, Lohi  J, Merras-Salmio  L, Koivusalo  A, Pakarinen  MP. Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure. J Hepatol  2021;74 :593–602 33002568
62 Hukkinen  M, Kivisaari  R, Merras-Salmio  L, Koivusalo  A, Pakarinen  MP. Small bowel dilatation predicts prolonged parenteral nutrition and decreased survival in pediatric short bowel syndrome. Ann Surg  2017;266 :369–375 27433892
63 Culbreath  K, Keefe  G, Nes  E, Staffa  SJ, Carey  AN, Jaksic  T  et al  Factors associated with chronic intestinal inflammation resembling inflammatory bowel disease in pediatric intestinal failure: a matched case-control study. J Pediatr Gastroenterol Nutr  2023;76 :468–474 36720109
64 Culbreath  K, Knell  J, Keefe  G, Han  SM, Hong  CR, Riley  HB  et al  Antibiotic therapy for culture-proven bacterial overgrowth in children with intestinal failure results in improved symptoms and growth. J Pediatr Gastroenterol Nutr  2022;75 :345–350 35653418
65 Fusaro  F, Tambucci  R, Romeo  E, Bagolan  P, Dall’Oglio  L, Ceccarelli  S  et al  Anastomotic ulcers in short bowel syndrome: new suggestions from a multidisciplinary approach. J Pediatr Surg  2018;53 :483–488 28610705
66 Hukkinen  M, Mutanen  A, Pakarinen  MP. Small bowel dilation in children with short bowel syndrome is associated with mucosal damage, bowel-derived bloodstream infections, and hepatic injury. Surgery  2017;162 :670–679 28689603
67 Pajunen  S, Mutanen  A, Kivisaari  R, Merras-Salmio  L, Pakarinen  MP. Long-term outcomes after autologous intestinal reconstructive surgery in children with short bowel syndrome. J Pediatr Gastroenterol Nutr  2023;76 :553–559 36754083
68 Talathi  S, Namjoshi  S, Raghu  V, Wendel  D, Oliveira  SB, Reed  K  et al  Evaluation and management of iron deficiency in children undergoing intestinal rehabilitation—a position paper from the NASPGHAN intestinal rehabilitation special interest group. J Pediatr Gastroenterol Nutr  2023;76 :672–683 36800275
69 Charbit-Henrion  F, Chardot  C, Ruemmele  F, Talbotec  C, Morali  A, Goulet  O  et al  Anastomotic ulcerations after intestinal resection in infancy. J Pediatr Gastroenterol Nutr  2014;59 :531–536 24979478
70 Kinberg  S, Verma  T, Kaura  D, Mercer  DF. Optimizing transition from pediatric to adult care in short bowel syndrome and intestinal failure. J Parenter Enteral Nutr  2023;47 :718–728
71 Cuerda  C, Pironi  L, Arends  J, Bozzetti  F, Gillanders  L, Jeppesen  PB  et al  ESPEN practical guideline: clinical nutrition in chronic intestinal failure. Clinical Nutrition  2021;40 :5196–5220 34479179
72 Nightingale  J . Guidelines for management of patients with a short bowel. Gut  2006;55 :iv1–iv12 16837533
73 Best  KE, Tennant  PWG, Addor  M-C, Bianchi  F, Boyd  P, Calzolari  E  et al  Epidemiology of small intestinal atresia in Europe: a register-based study. Arch Dis Child Fetal Neonatal Ed  2012;97 :F353–F358 22933095
74 Sabbatini  S, Ganji  N, Chusilp  S, Balsamo  F, Li  B, Pierro  A. Intestinal atresia and necrotizing enterocolitis: embryology and anatomy. Semin Pediatr Surg  2022;31 :151234 36417784
75 Shawis  R, Antao  B. Prenatal bowel dilatation and the subsequent postnatal management. Early Hum Dev  2006;82 :297–303 16626900
76 Bethell  GS, Long  A-M, Knight  M, Hall  NJ. Congenital duodenal obstruction in the UK: a population-based study. Arch Dis Child Fetal Neonatal Ed  2020;105 :178–183 31229958
77 Mentessidou  A, Saxena  AK. Laparoscopic repair of duodenal atresia: systematic review and meta-analysis. World J Surg  2017;41 :2178–2184 28258456
78 Zhang  J, Xu  X, Wang  X, Zhao  L, Lv  Y, Chen  K. Laparoscopic versus open repair of congenital duodenal obstruction: a systematic review and meta-analysis. Pediatr Surg Int  2022;38 :1507–1515 36053328
79 Kimura  K, Mukohara  N, Nishijima  E, Muraji  T, Tsugawa  C, Matsumoto  Y. Diamond-shaped anastomosis for duodenal atresia: an experience with 44 patients over 15 years. J Pediatr Surg  1990;25 :977–979 2213450
80 Zani  A, Yeh  J-PB, King  SK, Chiu  PPL, Wales  PW. Duodeno-duodenostomy or duodeno-jejunostomy for duodenal atresia: is one repair better than the other?  Pediatr Surg Int  2017;33 :245–248 27858187
81 Lum Min  SA, Imam  M, Zrinyi  A, Shawyer  AC, Keijzer  R. Post-discharge follow-up of congenital duodenal obstruction patients: a systematic review. Pediatr Surg Int  2023;39 :239 37490166
82 Escobar  MA, Ladd  AP, Grosfeld  JL, West  KW, Rescorla  FJ, Scherer  LR  et al  Duodenal atresia and stenosis: long-term follow-up over 30 years. J Pediatr Surg  2004;39 :867–871 15185215
83 Kokkonen  M-L, Kalima  T, Jääskeläinen  J, Louhimo  I. Duodenal atresia: late follow-up. J Pediatr Surg  1988;23 :216–220 3357136
84 Vinycomb  T, Browning  A, Jones  MLM, Hutson  JM, King  SK, Teague  WJ. Quality of life outcomes in children born with duodenal atresia. J Pediatr Surg  2020;55 :2111–2114 31955988
85 Baird  PA, MacDonald  EC. An epidemiologic study of congenital malformations of the anterior abdominal wall in more than half a million consecutive live births. Am J Hum Genet  1981;33 :470–478 6454342
86 Ghionzoli  M, James  CP, David  AL, Shah  D, Tan  AWC, Iskaros  J  et al  Gastroschisis with intestinal atresia—predictive value of antenatal diagnosis and outcome of postnatal treatment. J Pediatr Surg  2012;47 :322–328 22325384
87 Owen  A, Marven  S, Johnson  P, Kurinczuk  J, Spark  P, Draper  ES  et al  Gastroschisis: a national cohort study to describe contemporary surgical strategies and outcomes. J Pediatr Surg  2010;45 :1808–1816 20850625
88 Bergholz  R, Boettcher  M, Reinshagen  K, Wenke  K. Complex gastroschisis is a different entity to simple gastroschisis affecting morbidity and mortality—a systematic review and meta-analysis. J Pediatr Surg  2014;49 :1527–1532 25280661
89 Emil  S, Canvasser  N, Chen  T, Friedrich  E, Su  W. Contemporary 2-year outcomes of complex gastroschisis. J Pediatr Surg  2012;47 :1521–1528 22901911
90 Bhat  V, Moront  M, Bhandari  V. Gastroschisis: a state-of-the-art review. Children  2020;7 :302 33348575
91 Skarsgard  ED . Management of gastroschisis. Curr Opin Pediatr  2016;28 :363–369 26974976
92 Santiago-Munoz  PC, McIntire  DD, Barber  RG, Megison  SM, Twickler  DM, Dashe  JS. Outcomes of pregnancies with fetal gastroschisis. Obstet Gynecol  2007;110 :663–668 17766615
93 Bradnock  TJ, Marven  S, Owen  A, Johnson  P, Kurinczuk  JJ, Spark  P  et al  Gastroschisis: one year outcomes from national cohort study. BMJ  2011;343 :d6749–d6749 22089731
94 Langer  JC, Longaker  MT, Crombleholme  TM, Bond  SJ, Finkbeiner  WE, Rudolph  CA  et al  Etiology of intestinal damage in gastroschisis. I: effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg  1989;24 :992–997 2530329
95 Ferreira  RG, Mendonça  CR, Gonçalves Ramos  LL, de Abreu Tacon  FS, Naves do Amaral  W  et al  Gastroschisis: a systematic review of diagnosis, prognosis and treatment. J Matern Fetal Neonatal Med  2022;35 :6199–6212 33899664
96 van Eijck  FC, Wijnen  RMH, van Goor  H. The incidence and morbidity of adhesions after treatment of neonates with gastroschisis and omphalocele: a 30-year review. J Pediatr Surg  2008;43 :479–483 18358285
97 Koivusalo  A, Lindahl  H, Rintala  RJ. Morbidity and quality of life in adult patients with a congenital abdominal wall defect: a questionnaire survey. J Pediatr Surg  2002;37 :1594–1601 12407546
98 Suominen  J, Rintala  R. Medium and long-term outcomes of gastroschisis. Semin Pediatr Surg  2018;27 :327–329 30413265
99 Ceccanti  S, Migliara  G, De Vito  C, Cozzi  DA. Prevalence, management, and outcome of cryptorchidism associated with gastroschisis: a systematic review and meta-analysis. J Pediatr Surg  2022;57 :1414–1422 34344532
100 Yardley  IE, Bostock  E, Jones  MO, Turnock  RR, Corbett  HJ, Losty  PD. Congenital abdominal wall defects and testicular maldescent—a 10-year single-center experience. J Pediatr Surg  2012;47 :1118–1122 22703780
101 Fraser  JA, Deans  KJ, Fallat  ME, Helmrath  M, Kabre  R, Leys  CM  et al  Evaluating the risk of peri-umbilical hernia after sutured or sutureless gastroschisis closure. J Pediatr Surg  2022;57 :786–791 35450699
102 Choi  WW, McBride  CA, Bourke  C, Borzi  P, Choo  K, Walker  R  et al  Long-term review of sutureless ward reduction in neonates with gastroschisis in the neonatal unit. J Pediatr Surg  2012;47 :1516–1520 22901910
103 De Bie  F, Swaminathan  V, Johnson  G, Monos  S, Adzick  NS, Laje  P. Long-term core outcomes of patients with simple gastroschisis. J Pediatr Surg  2021;56 :1365–1369 33012557
104 Arnold  HE, Baxter  KJ, Short  HL, Travers  C, Bhatia  A, Durham  MM  et al  Short-term and family-reported long-term outcomes of simple versus complicated gastroschisis. J Surg Res  2018;224 :79–88 29506856
105 Baerg  JE, Munoz  AN. Long term complications and outcomes in omphalocele. Semin Pediatr Surg  2019;28 :118–121 31072460
106 Boyd  PA, Tonks  AM, Rankin  J, Rounding  C, Wellesley  D, Draper  ES  et al  Monitoring the prenatal detection of structural fetal congenital anomalies in England and Wales: register-based study. J Med Screen  2011;18 :2–7 21536809
107 Lakshminarayanan  B, Lakhoo  K. Abdominal wall defects. Early Hum Dev  2014;90 :917–920 25448781
108 Long  A-M, Davenport  M, Kurinczuk  J, Knight  M. Defect size to weight ratio as a predictor of mode of closure in exomphalos: a national population study. 2017. https://congress.baps.org.uk/wp-content/uploads/2017/05/BAPS-Congress-2017-001.pdf (accessed 1 August 2023)
109 Van Eijck  FC, Aronson  DA, Hoogeveen  YL, Wijnen  RMH. Past and current surgical treatment of giant omphalocele: outcome of a questionnaire sent to authors. J Pediatr Surg  2011;46 :482–488 21376197
110 Levy  S, Tsao  K, Cox  CS, Phatak  UR, Lally  KP, Andrassy  RJ. Component separation for complex congenital abdominal wall defects: not just for adults anymore. J Pediatr Surg  2013;48 :2525–2529 24314197
111 Christison-Lagay  ER, Kelleher  CM, Langer  JC. Neonatal abdominal wall defects. Semin Fetal Neonatal Med  2011;16 :164–172 21474399
112 Lauriti  G, Miscia  ME, Cascini  V, Chiesa  PL, Pierro  A, Zani  A. Intestinal malrotation in infants with omphalocele: a systematic review and meta-analysis. J Pediatr Surg  2019;54 :378–382 30309732
113 Gamba  P, Midrio  P. Abdominal wall defects: prenatal diagnosis, newborn management, and long-term outcomes. Semin Pediatr Surg  2014;23 :283–290 25459013
114 Gazzin  A, Carli  D, Sirchia  F, Molinatto  C, Cardaropoli  S, Palumbo  G  et al  Phenotype evolution and health issues of adults with Beckwith-Wiedemann syndrome. Am J Med Genet A  2019;179 :1691–1702 31339634
115 Mussa  A, Di Candia  S, Russo  S, Catania  S, De Pellegrin  M, Di Luzio  L  et al  Recommendations of the Scientific Committee of the Italian Beckwith-Wiedemann Syndrome Association on the diagnosis, management and follow-up of the syndrome. Eur J Med Genet  2016;59 :52–64 26592461
116 van Eijck  FC, Hoogeveen  YL, van Weel  C, Rieu  PNMA, Wijnen  RMH. Minor and giant omphalocele: long-term outcomes and quality of life. J Pediatr Surg  2009;44 :1355–1359 19573661
117 Todani  T, Watanabe  Y, Narusue  M, Tabuchi  K, Okajima  K. Congenital bile duct cysts. Am J Surg  1977;134 :263–269 889044
118 Cazares  J, Koga  H, Yamataka  A. Choledochal cyst. Pediatr Surg Int  2023;39 :209 37261604
119 Hukkinen  M, Björnland  K, Gatzinsky  V, Iber  T, Johansen  LS, Qvist  N  et al  Management strategies and treatment results of pediatric choledochal malformations in the Nordic countries. HPB (Oxford)  2020;22 :161–168 31371244
120 Soares  KC, Kim  Y, Spolverato  G, Maithel  S, Bauer  TW, Marques  H  et al  Presentation and clinical outcomes of choledochal cysts in children and adults: a multi-institutional analysis. JAMA Surg  2015;150 :577 25923827
121 Mehta  V, Hopson  PE, Smadi  Y, Patel  SB, Horvath  K, Mehta  DI. Development of the human pancreas and its exocrine function. Front Pediatr  2022;10 :909648 36245741
122 Babbitt  DP . Congenital choledochal cysts: new etiological concept based on anomalous relationships of the common bile duct and pancreatic bulb. Ann Radiol (Paris)  1969;12 :231–240 5401505
123 Van Den Eijnden  MHA, De Kleine  RH, De Blaauw  I, Peeters  PMJG, Koot  BGP, Oomen  MWN  et al  The timing of surgery of antenatally diagnosed choledochal malformations: a descriptive analysis of a 26-year nationwide cohort. J Pediatr Surg  2017;52 :1156–1160 28318597
124 Hulscher  JBF, Kuebler  JF, Bruggink  JM, Davenport  M, Scholz  S, Petersen  C  et al  Controversies in choledochal malformation in children: an international survey among pediatric hepatobiliary surgeons and gastroenterologists. J Clin Med  2022;11 :1148 35207421
125 de Kleine  RH, ten Hove  A, Hulscher  JBF. Long-term morbidity and follow-up after choledochal malformation surgery; a plea for a quality of life study. Semin Pediatr Surg  2020;29 :150942 32861446
126 Yeung  F, Fung  ACH, Chung  PHY, Wong  KKY. Short-term and long-term outcomes after Roux-en-Y hepaticojejunostomy versus hepaticoduodenostomy following laparoscopic excision of choledochal cyst in children. Surg Endosc  2020;34 :2172–2177 31342261
127 Guzman  JPS, Resurreccion III  LL, Suntay  MLR, Bernaldez  RG. Comparison between hepaticojejunostomy and hepaticoduodenostomy after excision of choledochal cyst in children: a cohort study. World J Ped Surgery  2019;2 :e000029
128 Morikawa  T, Ohtsuka  H, Takadate  T, Ishida  M, Miura  T, Mizuma  M  et al  Laparoscopic and robot-assisted surgery for adult congenital biliary dilatation achieves favorable short-term outcomes without increasing the risk of late complications. Surg Today  2022;52 :1039–1047 35079896
129 Urushihara  N, Fukumoto  K, Nouso  H, Yamoto  M, Miyake  H, Kaneshiro  M  et al  Hepatic ductoplasty and hepaticojejunostomy to treat narrow common hepatic duct during laparoscopic surgery for choledochal cyst. Pediatr Surg Int  2015;31 :983–986 26272076
130 Ohtsuka  H, Fukase  K, Yoshida  H, Motoi  F, Hayashi  H, Morikawa  T  et al  Long-term outcomes after extrahepatic excision of congenital choladocal cysts: 30 years of experience at a single center. Hepatogastroenterology  2015;62 :1–5 25911857
131 Nguyen  HV, Do  DH, Nguyen  HV, Vu  TH, Hong  QQ, Vo  CT  et al  Treatment of complex complications after choledochal cyst resection by multiple minimal invasive therapies: a case report. Int J Surg Case Rep  2020;73 :130–133 32683084
132 Tsuchida  Y, Takahashi  A, Suzuki  N, Kuroiwa  M, Murai  H, Toki  F  et al  Development of intrahepatic biliary stones after excision of choledochal cysts. J Pediatr Surg  2002;37 :165–167 11819192
133 Madadi-Sanjani  O, Wirth  T, Kuebler  J, Petersen  C, Ure  B. Choledochal cyst and malignancy: a plea for lifelong follow-up. Eur J Pediatr Surg  2019;29 :143–149 29258149
134 Kleine  RH, Schreuder  AM, Hove  A, Hulscher  JBF, Borel Rinkes  IHM, Dejong  CHC  et al  Choledochal malformations in adults in The Netherlands: results from a nationwide retrospective cohort study. Liver Int  2020;40 :2469–2475 32562356
135 Xia  H-T, Yang  T, Liang  B, Zeng  J-P, Dong  J-H. Treatment and outcomes of adults with remnant intrapancreatic choledochal cysts. Surgery  2016;159 :418–425 26126795
136 ten Hove  A, de Meijer  VE, Hulscher  JBF, de Kleine  RHJ. Meta-analysis of risk of developing malignancy in congenital choledochal malformation. Br J Surg  2018;105 :482–490 29480528
137 Hyvärinen  I, Hukkinen  M, Kivisaari  R, Kylänpää  L, Nordin  A, Mäkisalo  H  et al  Characteristics, management and outcomes of choledochal malformations in Finnish adult patients. Scand J Gastroenterol  2023;58 :1038–1043 37070861
138 Hosokawa  T, Hosokawa  M, Shibuki  S, Tanami  Y, Sato  Y, Ishimaru  T  et al  Role of ultrasound in follow-up after choledochal cyst surgery. J Med Ultrasonics  2021;48 :21–29
139 Hyvärinen  I, Hukkinen  M, Kivisaari  R, Parviainen  H, Mäkisalo  H, Koivusalo  A  et al  Long-term morbidity of choledochal malformations in children. J Pediatr Gastroenterol Nutr  2021;72 :820–825 33470752
140 Aspelund  G, Mahdi  EM, Rothstein  DH, Wakeman  DS, American Academy of Pediatrics Section on Surgery’s Delivery of Surgical Care Committee. Transitional care for patients with surgical pediatric hepatobiliary disease: choledochal cysts and biliary atresia. J Gastroenterol Hepatol  2019;34 :966–974 30552863
141 Samyn  M . Transitional care of biliary atresia. Semin Pediatr Surg  2020;29 :150948 32861452
142 Hartley  JL, Davenport  M, Kelly  DA. Biliary atresia. Lancet  2009;374 :1704–1713 19914515
143 Chung  PHY, Zheng  S, Tam  PKH. Biliary atresia: East versus West. Semin Pediatr Surg  2020;29 :150950 32861448
144 Sergi  CM, Gilmour  S. Biliary atresia: a complex hepatobiliary disease with variable gene involvement, diagnostic procedures, and prognosis. Diagnostics  2022;12 :330 35204421
145 Lopez  RN, Ooi  CY, Krishnan  U. Early and peri-operative prognostic indicators in infants undergoing hepatic portoenterostomy for biliary atresia: a review. Curr Gastroenterol Rep  2017;19 :16 28374309
146 Wang  J, Xu  Y, Chen  Z, Liang  J, Lin  Z, Liang  H  et al  Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia. Cell  2020;183 :1867–1883.e26 33248023
147 Tucker  RM, Feldman  AG, Fenner  EK, Mack  CL. Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia. J Hepatol  2013;59 :790–796 23685050
148 Davenport  M, Muntean  A, Hadzic  N. Biliary atresia: clinical phenotypes and aetiological heterogeneity. J Clin Med  2021;10 :5675 34884377
149 Kasai  M, Suzuki  H, Ohashi  E, Ohi  R, Chiba  T, Okamoto  A. Technique and results of operative management of biliary atresia. World J Surg  1978;2 :571–579 741761
150 Chung  PHY, Chan  EKW, Yeung  F, Chan  ACY, Mou  JWC, Lee  KH  et al  Life long follow up and management strategies of patients living with native livers after Kasai portoenterostomy. Sci Rep  2021;11 :11207 34045634
151 Nio  M . Japanese biliary atresia registry. Pediatr Surg Int  2017;33 :1319–1325 29039049
152 Parolini  F, Boroni  G, Milianti  S, Tonegatti  L, Armellini  A, Garcia Magne  M  et al  Biliary atresia: 20–40-year follow-up with native liver in an Italian centre. J Pediatr Surg  2019;54 :1440–1444 30502004
153 Davenport  M, Ong  E, Sharif  K, Alizai  N, McClean  P, Hadzic  N  et al  Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg  2011;46 :1689–1694 21929975
154 Fanna  M, Masson  G, Capito  C, Girard  M, Guerin  F, Hermeziu  B  et al  Management of biliary atresia in France 1986 to 2015: long-term results. J Pediatr Gastroenterol Nutr  2019;69 :416–424 31335841
155 Pakarinen  MP, Johansen  LS, Svensson  JF, Bjørnland  K, Gatzinsky  V, Stenström  P  et al  Outcomes of biliary atresia in the Nordic countries—a multicenter study of 158 patients during 2005–2016. J Pediatr Surg  2018;53 :1509–1515 28947328
156 Shneider  BL, Magee  JC, Karpen  SJ, Rand  EB, Narkewicz  MR, Bass  LM  et al  Total serum bilirubin within 3 months of hepatoportoenterostomy predicts short-term outcomes in biliary atresia. J Pediatr  2016;170 :211–217.e1-2 26725209
157 Hoshino  E, Muto  Y, Sakai  K, Shimohata  N, Urayama  KY, Suzuki  M. Age at surgery and native liver survival in biliary atresia: a systematic review and meta-analysis. Eur J Pediatr  2023;182 :2693–2704 36997770
158 Kelly  DA, Davenport  M. Current management of biliary atresia. Arch Dis Child  2007;92 :1132–1135 17878208
159 Parolini  F, Hadzic  N, Davenport  M. Adjuvant therapy of cytomegalovirus IgM +ve associated biliary atresia: prima facie evidence of effect. J Pediatr Surg  2019;54 :1941–1945 30772005
160 Liliemark  U, Svensson  JF, Fischler  B. Incidence and antiviral treatment of cytomegalovirus infection in infants with biliary atresia. Pediatr Surg Int  2023;39 :117 36773050
161 Lu  X, Jiang  J, Shen  Z, Chen  G, Np  YW, Xiao  X  et al  Effect of adjuvant steroid therapy in type 3 biliary atresia: a single-center, open-label, randomized controlled trial. Ann Surg  2023;277 :e1200–e1207 35170539
162 Yang  C, Zhou  Y, Ke  M, Gao  R, Ye  S, Diao  M  et al  Effects of postoperative adjuvant steroid therapy on the outcomes of biliary atresia: a systematic review and updated meta-analysis. Front Pharmacol  2022;13 :956093 36188593
163 Chung  PH, Wong  KK, Tam  PK. Standard management protocol to improve the short-term outcome of biliary atresia. J Paediatr Child Health  2020;56 :1774–1778 33197970
164 Ge  L, Zhan  J, Gao  W, Zhao  S, Xu  X, Dou  R. Relevant factors for early liver transplantation after Kasai portoenterostomy. BMC Pediatr  2020;20 :484 33081738
165 Taylor  SA, Venkat  V, Arnon  R, Gopalareddy  VV, Rosenthal  P, Erinjeri  J  et al  Improved outcomes for liver transplantation in patients with biliary atresia since pediatric end-stage liver disease implementation: analysis of the Society of Pediatric Liver Transplantation registry. J Pediatr  2020;219 :89–97 32005543
166 Hukkinen  M, Ruuska  S, Pihlajoki  M, Kyrönlahti  A, Pakarinen  MP. Long-term outcomes of biliary atresia patients surviving with their native livers. Best Pract Res Clin Gastroenterol  2022;56–57 :101764
167 Wong  CWY, Chung  PHY, Tam  PKH, Wong  KKY. Long-term results and quality of life assessment in biliary atresia patients: a 35-year experience in a tertiary hospital. J Pediatr Gastroenterol Nutr  2018;66 :570–574 29216021
168 Le  M, Reinshagen  K, Tomuschat  C. Systematic review: the quality of life of patients with biliary atresia. J Pediatr Surg  2022;57 :934–946 35428492
169 Westbrook  RH, Yeoman  AD, Grady  O, Harrison  JG, Devlin  PM, Heneghan  J  et al  Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol  2011;9 :694–699 21570482
170 Jain  V, Burford  C, Alexander  EC, Sutton  H, Dhawan  A, Joshi  D  et al  Prognostic markers at adolescence in patients requiring liver transplantation for biliary atresia in adulthood. J Hepatol  2019;71 :71–77 30876944
171 Kyrklund  K, Sloots  CEJ, de Blaauw  I, Bjørnland  K, Rolle  U, Cavalieri  D  et al  ERNICA guidelines for the management of rectosigmoid Hirschsprung’s disease. Orphanet J Rare Dis  2020;15 :164 32586397
172 Kawaguchi  AL, Guner  YS, Sømme  S, Quesenberry  AC, Arthur  LG, Sola  JE  et al  Management and outcomes for long-segment Hirschsprung disease: a systematic review from the APSA outcomes and evidence based practice committee. J Pediatr Surg  2021;56 :1513–1523 33993978
173 Heuckeroth  RO . Hirschsprung disease—integrating basic science and clinical medicine to improve outcomes. Nat Rev Gastroenterol Hepatol  2018;15 :152–167 29300049
174 de Beaufort  CMC, Aminoff  D, de Blaauw  I, Crétolle  C, Dingemann  J, Durkin  N  et al  Transitional care for patients with congenital colorectal diseases: an EUPSA network office, ERNICA, and eUROGEN joint venture. J Pediatr Surg  2023;58 :2319–2326 37438237
175 Dasgupta  R, Langer  JC. Hirschsprung disease. Curr Probl Surg  2004;41 :949–988
176 Payen  E, Talbotec  C, Chardot  C, Capito  C, Khen-Dunlop  N, Sarnacki  S  et al  Outcome of total colonic aganglionosis involving the small bowel depends on bowel length, liver disease, and enterocolitis. J Pediatr Gastroenterol Nutr  2022;74 :582–587 35175997
177 Rintala  RJ, Pakarinen  MP. Long-term outcomes of Hirschsprung’s disease. Semin Pediatr Surg  2012;21 :336–343 22985839
178 Ambartsumyan  L, Patel  D, Kapavarapu  P, Medina-Centeno  RA, El-Chammas  K, Khlevner  J  et al  Evaluation and management of postsurgical patient with Hirschsprung disease Neurogastroenterology & Motility Committee: position paper of North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr  2023;76 :533–546 36720091
179 Neuvonen  MI, Kyrklund  K, Rintala  RJ, Pakarinen  MP. Bowel function and quality of life after transanal endorectal pull-through for Hirschsprung disease: controlled outcomes up to adulthood. Ann Surg  2017;265 :622–629 28169931
180 Langer  JC, Rollins  MD, Levitt  M, Gosain  A, de la Torre  L, Kapur  RP  et al. Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease. Pediatr Surg Int  2017;33 :523–526 28180937
181 Jarvi  K, Laitakari  EM, Koivusalo  A, Rintala  RJ, Pakarinen  MP. Bowel function and gastrointestinal quality of life among adults operated for Hirschsprung disease during childhood: a population-based study. Ann Surg  2010;252 :977–981 21107107
182 Saadai  P, Trappey  AF, Goldstein  AM, Cowles  RA, De La Torre  L, Durham  MM  et al  Guidelines for the management of postoperative soiling in children with Hirschsprung disease. Pediatr Surg Int  2019;35 :829–834 31201486
183 Meinds  RJ, van der Steeg  AFW, Sloots  CEJ, Witvliet  MJ, de Blaauw  I, van Gemert  WG  et al  Long-term functional outcomes and quality of life in patients with Hirschsprung’s disease. Br J Surg  2019;106 :499–507 30653654
184 Davidson  JR, Mutanen  A, Salli  M, Kyrklund  K, De Coppi  P, Curry  J  et al  Comparative cohort study of Duhamel and endorectal pull-through for Hirschsprung’s disease. BJS Open  2022;6 :zrab143 35143630
185 Kyrklund  K, Neuvonen  M, Pakarinen  M, Rintala  R. Social morbidity in relation to bowel functional outcomes and quality of life in anorectal malformations and Hirschsprung’s disease. Eur J Pediatr Surg  2018;28 :522–528 29059696
186 Davidson  JR, Kyrklund  K, Eaton  S, Pakarinen  MP, Thompson  DS, Cross  K  et al  Sexual function, quality of life, and fertility in women who had surgery for neonatal Hirschsprung’s disease. Br J Surg  2021;108 :e79–e80 33711127
187 Neuvonen  M, Kyrklund  K, Taskinen  S, Koivusalo  A, Rintala  RJ, Pakarinen  MP. Lower urinary tract symptoms and sexual functions after endorectal pull-through for Hirschsprung disease: controlled long-term outcomes. J Pediatr Surg  2017;52 :1296–1301 28341232
188 Hoel  AT, Karlsen  RA, Fosby  MV, Bjørnland  K. Sexual function and lower urinary tract symptoms after minimally invasive endorectal pull-through in adolescent males with Hirschsprung disease. J Pediatr Surg  2023;58 :490–495 36283850
189 Granström  AL, Ludvigsson  JF, Wester  T. Clinical characteristics and validation of diagnosis in individuals with Hirschsprung disease and inflammatory bowel disease. J Pediatr Surg  2021;56 :1799–1802 33276971
190 Virtanen  VB, Pukkala  E, Kivisaari  R, Salo  PP, Koivusalo  A, Arola  J  et al  Thyroid cancer and co-occurring RET mutations in Hirschsprung disease. Endocr Relat Cancer  2013;20 :595–602 23744765
191 Plascevic  J, Shah  S, Tan  Y-W. Transitional care in anorectal malformation and Hirschsprung’s disease: a systematic review of challenges and solutions. J Pediatr Surg  2023:S00223468(23)00678-4
192 Violani  C, Grano  C, Fernandes  M, Prato  AP, Feitz  WFJ, Wijnen  R  et al  The transition of care for patients with anorectal malformations and Hirschsprung disease: a European survey. Eur J Pediatr Surg  2023;33 :191–197 35830861
193 Rintala  RJ, Pakarinen  MP. Outcome of anorectal malformations and Hirschsprung’s disease beyond childhood. Semin Pediatr Surg  2010;19 :160–167 20307853
194 Kluth  D, Hillen  M, Lambrecht  W. The principles of normal and abnormal hindgut development. J Pediatr Surg  1995;30 :1143–1147 7472968
195 Holschneider  A, Hutson  J, Peña  A, Beket  E, Chatterjee  S, Coran  A  et al  Preliminary report on the International Conference for the Development of Standards for the Treatment of Anorectal Malformations. J Pediatr Surg  2005;40 :1521–1526 16226976
196 Peña  A, Devries  PA. Posterior sagittal anorectoplasty: important technical considerations and new applications. J Pediatr Surg  1982;17 :796–811 6761417
197 Kyrklund  K, Pakarinen  MP, Rintala  RJ. Long-term bowel function, quality of life and sexual function in patients with anorectal malformations treated during the PSARP era. Semin Pediatr Surg  2017;26 :336–342 29110831
198 Bjoersum-Meyer  T, Kaalby  L, Lund  L, Christensen  P, Jakobsen  MS, Baatrup  G  et al  Long-term functional urinary and sexual outcomes in patients with anorectal malformations—a systematic review. Eur Urol Open Sci  2021;25 :29–38 34337501
199 Örtqvist  L, Holmdahl  G, Borg  H, Bjornland  K, Lilja  H, Stenström  P  et al  Bowel control, bladder function, and quality of life in children with cloacal malformations. J Pediatr Surg  2023;58 :1942–1948 36635159
200 Rintala  RJ . Congenital cloaca: long-term follow-up results with emphasis on outcomes beyond childhood. Semin Pediatr Surg  2016;25 :112–116 26969236
201 Wehrli  LA, Reppucci  ML, Woodfield  K, Ketzer  J, Rieck  JM, Cooper  EH  et al  Fertility concerns and outcomes in females with anorectal malformations. Pediatr Surg Int  2023;39 :228 37422894
202 Doktor  F, Antounians  L, Lacher  M, Zani  A. Congenital lung malformations: dysregulated lung developmental processes and altered signaling pathways. Semin Pediatr Surg  2022;31 :151228 36442455
203 Lau  CT, Kan  A, Shek  N, Tam  P, Wong  KKY. Is congenital pulmonary airway malformation really a rare disease? Result of a prospective registry with universal antenatal screening program. Pediatr Surg Int  2017;33 :105–108 27770196
204 Fowler  DJ, Gould  SJ. The pathology of congenital lung lesions. Semin Pediatr Surg  2015;24 :176–182 26051050
205 Wall  J, Coates  A. Prenatal imaging and postnatal presentation, diagnosis and management of congenital lung malformations. Curr Opin Pediatr  2014;26 :315–319 24739492
206 Penikis  AB, Zhou  AL, Sferra  SR, Engwall-Gill  AJ, Miller  JL, Baschat  AA  et al  Serial lung mass volume ratios as prognostic indicators of neonatal respiratory morbidity in fetal pulmonary malformations. Am J Obstet Gynecol MFM  2023;5 :101128 37572880
207 Sacco  A, Van der Veeken  L, Bagshaw  E, Ferguson  C, Van Mieghem  T, David  AL  et al  Maternal complications following open and fetoscopic fetal surgery: a systematic review and meta-analysis. Prenat Diagn  2019;39 :251–268 30703262
208 Bose  SK, Stratigis  JD, Ahn  N, Pogoriler  J, Hedrick  HL, Rintoul  NE  et al  Prenatally diagnosed large lung lesions: timing of resection and perinatal outcomes. J Pediatr Surg  2023;58 :2384–2390 37813715
209 Kersten  CM, Hermelijn  SM, Dossche  LWJ, Muthialu  N, Losty  PD, Schurink  M  et al  Collaborative neonatal network for the first European CPAM trial (CONNECT): a study protocol for a randomised controlled trial. BMJ Open  2023;13 :e071989
210 ICLMR . International Congenital Lung Malformation Registry. [cited 14 Sep 2023]. Available at: http://www.iclmr.org
211 Wong  A, Vieten  D, Singh  S, Harvey  JG, Holland  AJA. Long-term outcome of asymptomatic patients with congenital cystic adenomatoid malformation. Pediatr Surg Int  2009;25 :479–485 19404649
212 Patrizi  S, Pederiva  F, d’Adamo  AP. Whole-genome methylation study of congenital lung malformations in children. Front Oncol  2021;11 :689833 34262872
213 Hsu  JS, Zhang  R, Yeung  F, Tang  CSM, Wong  JKL, So  M-T  et al  Cancer gene mutations in congenital pulmonary airway malformation patients. ERJ Open Res  2019;5 :00196–02018 30740464
214 Karlsson  M, Conner  P, Ehren  H, Bitkover  C, Burgos  CM. The natural history of prenatally diagnosed congenital pulmonary airway malformations and bronchopulmonary sequestrations. J Pediatr Surg  2022;57 :282–287 35431039
215 Ng  C, Stanwell  J, Burge  DM, Stanton  MP. Conservative management of antenatally diagnosed cystic lung malformations. Arch Dis Child  2014;99 :432–437 24406806
216 Cook  J, Chitty  LS, De Coppi  P, Ashworth  M, Wallis  C. The natural history of prenatally diagnosed congenital cystic lung lesions: long-term follow-up of 119 cases. Arch Dis Child  2017;102 :798–803 28584070
217 Bonnard  A . Thoracoscopic lobectomy for congenital pulmonary airway malformation: where are we in 2019?  Eur J Pediatr Surg  2020;30 :146–149 32146716
218 Rothenberg  SS . Thoracoscopic lobectomy in infants and children. J Laparoendosc Adv Surg Tech  2021;31 :1157–1161
219 Duron  V, Zenilman  A, Griggs  C, DeFazio  J, Price  JC, Fan  W  et al  Asymptomatic congenital lung malformations: timing of resection does not affect adverse surgical outcomes. Front Pediatr  2020;8 :35 32117840
220 Lau  CT, Wong  KKY, Tam  P. Medium term pulmonary function test after thoracoscopic lobectomy for congenital pulmonary airway malformation: a comparative study with normal control. J Laparoendosc Adv Surg Tech  2018;28 :595–598
221 Lam  FKF, Lau  C-T, Mo  Y, Wong  KKY. Comparison of thoracoscopy vs. thoracotomy on musculoskeletal outcomes of children with congenital pulmonary airway malformation (CPAM). J Pediatr Surg  2021;56 :1732–1736 33551147
222 Pogoriler  J, Swarr  D, Kreiger  P, Adzick  NS, Peranteau  W. Congenital cystic lung lesions: redefining the natural distribution of subtypes and assessing the risk of malignancy. Am J Surg Pathol  2019;43 :47–55 29266024
223 Dunn  A, Pearce  K, Callister  R, Collison  A, Morten  M, Mandaliya  P  et al  Exercise capacity is not decreased in children who have undergone lung resection early in life for congenital thoracic malformations compared to healthy age-matched children. Pediatr Pulmonol  2017;52 :1340–1348 28737279
224 Muntean  A, Banias  L-E, Ade-Ajayi  N, Patel  SB, McKinney  O, Davenport  M. Neonatal congenital pulmonary airway malformation associated with mucinous adenocarcinoma and KRAS mutations. J Pediatr Surg  2022;57 :520–526 34980466
225 Hermelijn  SM, Wolf  JL, den Toom  D, Wijnen  T, Rottier  RMH, Schnater  RJ  et al  Early KRAS oncogenic driver mutations in nonmucinous tissue of congenital pulmonary airway malformations as an indicator of potential malignant behavior. Hum Pathol  2020;103 :95–106 32681943
226 Tassi  V, Daddi  N, Altimari  A, Gruppioni  E, Crinò  L, Rossi  G  et al  Sarcomatoid change in adenocarcinoma arising in adulthood congenital pulmonary airway malformation. Adv Respir Med  2022;90 :148–151
227 Frick  AE, Decaluwé  H, Weynand  B, Proesmans  M, Van Raemdonck  D. Invasive mucinous adenocarcinoma of the lung arising in a type 1 congenital pulmonary airway malformation in a 68-year-old patient: a case report. Acta Chir Belg  2021;121 :55–60 31262240
228 Losty  PD, Flake  AW, Rintala  RJ, Hutson  JM, lwai  N. Rickham’s Neonatal Surgery. London: Springer London, 2018
229 Jesudason  EC, Connell  MG, Fernig  DG, Lloyd  DA, Losty  PD. Early lung malformations in congenital diaphragmatic hernia. J Pediatr Surg  2000;35 :124–128 10646789
230 Keijzer  R, Liu  J, Deimling  J, Tibboel  D, Post  M. Dual-hit hypothesis explains pulmonary hypoplasia in the nitrofen model of congenital diaphragmatic hernia. Am J Pathol  2000;156 :1299–1306 10751355
231 Moyer  VA, Moya  FR, Tibboel  D, Losty  PD, Nagaya  M, Lally  KP. Late versus early surgical correction for congenital diaphragmatic hernia in newborn infants. Cochrane Database Syst Rev  2000;2010 :CD001695
232 Losty  PD . Congenital diaphragmatic hernia: where and what is the evidence?  Semin Pediatr Surg  2014;23 :278–282 25459012
233 Lally  KP, Lasky  RE, Lally  PA, Bagolan  P, Davis  CF, Frenckner  BP  et al  Standardized reporting for congenital diaphragmatic hernia—an international consensus. J Pediatr Surg  2013;48 :2408–2415 24314179
234 Jawaid  WB, Qasem  E, Jones  MO, Shaw  NJ, Losty  PD. Outcomes following prosthetic patch repair in newborns with congenital diaphragmatic hernia. Br J Surg  2013;100 :1833–1837 24227372
235 Lansdale  N, Alam  S, Losty  PD, Jesudason  EC. Neonatal endosurgical congenital diaphragmatic hernia repair: a systematic review and meta-analysis. Ann Surg  2010;252 :20–26 20505506
236 Puligandla  PS, Grabowski  J, Austin  M, Hedrick  H, Renaud  E, Arnold  M  et al  Management of congenital diaphragmatic hernia: a systematic review from the APSA outcomes and evidence based practice committee. J Pediatr Surg  2015;50 :1958–1970 26463502
237 Deprest  JA, Nicolaides  KH, Benachi  A, Gratacos  E, Ryan  G, Persico  N  et al  Randomized trial of fetal surgery for severe left diaphragmatic hernia. N Engl J Med  2021;385 :107–118 34106556
238 Ba’ath  ME, Jesudason  EC, Losty  PD. How useful is the lung-to-head ratio in predicting outcome in the fetus with congenital diaphragmatic hernia? A systematic review and meta-analysis. Ultrasound Obstet Gynecol  2007;30 :897–906 17963204
239 Mullassery  D, Ba’ath  ME, Jesudason  EC, Losty  PD. Value of liver herniation in prediction of outcome in fetal congenital diaphragmatic hernia: a systematic review and meta-analysis. Ultrasound Obstet Gynecol  2010;35 :609–614 20178116
240 Stolar  C, Flake  A, Losty  P. Fetal surgery for severe left diaphragmatic hernia. N Engl J Med  2021;385 :2111–2112 34818499
241 Jancelewicz  T, Chiang  M, Oliveira  C, Chiu  PP. Late surgical outcomes among congenital diaphragmatic hernia (CDH) patients: why long-term follow-up with surgeons is recommended. J Pediatr Surg  2013;48 :935–941 23701763
242 Lewis  L, Sinha  I, Kang  S-L, Lim  J, Losty  PD. Long term outcomes in CDH: cardiopulmonary outcomes and health related quality of life. J Pediatr Surg  2022;57 :501–509 35508437
243 Lewis  L, Sinha  I, Losty  PD. Clinical trials and outcome reporting in congenital diaphragmatic hernia overlook long-term health and functional outcomes—a plea for core outcomes. Acta Paediatr  2022;111 :1481–1489 35567507
244 Patel  N, Massolo  AC, Kraemer  US, Kipfmueller  F. The heart in congenital diaphragmatic hernia: knowns, unknowns, and future priorities. Front Pediatr  2022;10 :890422 36052357
245 Antounians  L, Zani  A. Beyond the diaphragm and the lung: a multisystem approach to understanding congenital diaphragmatic hernia. Pediatr Surg Int  2023;39 :194 37160490
246 Kraemer  US, Kamphuis  LS, Ciet  P, Visser  L, Tibboel  D, Bartelds  B  et al  Cardiopulmonary morbidity in adults born with congenital diaphragmatic hernia. Pediatrics  2023;152 :e2023062341 37750210
247 Power  B . The CDH patient perspective journey. Front Pediatr  2023;11 :1052422 36896399
248 Hollinger  LE, Buchmiller  TL. Long term follow-up in congenital diaphragmatic hernia. Semin Perinatol  2020;44 :151171 31451197
249 Losty  PD, La Quaglia  M, Sarnacki  S, Fuchs  J, Taguchi  T. Pediatric Surgical Oncology. (1st ed). Boca Raton: CRC Press, 2022
250 Fawkner-Corbett  DW, Howell  L, Pizer  BL, Dominici  C, McDowell  HP, Losty  PD. Wilms’ tumor—lessons and outcomes—a 25-year single center UK experience. Pediatr Hematol Oncol  2014;31 :400–408 24933082
251 Salim  A, Mullassery  D, Pizer  B, McDowell  HP, Losty  PD. Neuroblastoma: a 20-year experience in a UK regional centre: surgery management of neuroblastoma. Pediatr Blood Cancer  2011;57 :1254–1260 21523901
252 Irtan  S, Ehrlich  PF, Pritchard-Jones  K. Wilms tumor: “state-of-the-art” update, 2016. Semin Pediatr Surg  2016;25 :250–256 27955727
253 Terwisscha van Scheltinga  S, Rogers  T, Smeulders  N, deCorti  F, Guerin  F, Craigie  R  et al  Developments in the surgical approach to staging and resection of rhabdomyosarcoma. Cancers (Basel)  2023;15 :449 36672397
254 Olson  TA, Murray  MJ, Rodriguez-Galindo  C, Nicholson  JC, Billmire  DF, Krailo  MD  et al  Pediatric and adolescent extracranial germ cell tumors: the road to collaboration. J Clin Oncol  2015;33 :3018–3028 26304902
255 Woeste  MR, Bhutiani  N, Hong  YK, Shah  J, Kim  WE, Egger  M  et al  Primitive neuroectodermal tumor incidence, treatment patterns, and outcome: an analysis of the national cancer database. J Surg Oncol  2020;122 :1145–1151 32734604
256 Zimmermann  T, Blütters-Sawatzki  R, Flechsenhar  K, Padberg  WM. Peripheral primitive neuroectodermal tumor: challenge for multimodal treatment. World J Surg  2001;25 :1367–1372 11760735
257 Gao  L, Zhu  Y, Shi  X, Gao  Z, Chen  X. Peripheral primitive neuroectodermal tumors: a retrospective analysis of 89 cases and literature review. Oncol Lett  2019;18 :6885–6890 31788128
258 Cozzi  DA, Zani  A. Nephron-sparing surgery in children with primary renal tumor: indications and results. Semin Pediatr Surg  2006;15 :3–9 16458840
259 Vanden Berg  RNW, Bierman  EN, Noord  MV, Rice  HE, Routh  JC. Nephron-sparing surgery for Wilms tumor: a systematic review. Urol Oncol  2016;34 :24–32 26254695
260 Arthur  F, Hennessey  I, Pizer  B, Losty  PD. Surgical management and outcomes of paediatric ovarian tumours—a 25-year UK single centre experience. Pediatr Surg Int  2021;37 :1355–1359 34170394
261 Delehaye  F, Sarnacki  S, Orbach  D, Cheikhelard  A, Rouger  J, Parienti  J  et al  Lessons from a large nationwide cohort of 350 children with ovarian mature teratoma: a study in favor of ovarian-sparing surgery. Pediatr Blood Cancer  2022;69 :e29421 34842332
262 Bois  JI, Vagni  RL, de Badiola  FI, Moldes  JM, Losty  PD, Lobos  PA. Testis-sparing surgery for testicular tumors in children: a 20 year single center experience and systematic review of the literature. Pediatr Surg Int  2021;37 :607–616 33454815
263 Martucci  C, Crocoli  A, De Pasquale  MD, Spinelli  C, Strambi  S, Brazzarola  P  et al  Thyroid cancer in children: a multicenter international study highlighting clinical features and surgical outcomes of primary and secondary tumors. Front Pediatr  2022;10 :914942 35935364
264 Salim  A, Raitio  A, Losty  PD. Long-term functional outcomes of sacrococcygeal teratoma—a systematic review of published studies exploring ‘real world’ outcomes. Eur J Surg Oncol  2023;49 :16–20 36127201
265 Braungart  S, Craigie  R, Farrelly  P, Losty  P. Ovarian tumors in children: how common are lesion recurrence and metachronous disease? A UK CCLG Surgeons Cancer Group nationwide study. J Pediatr Surg  2020;55 :2026–2029 31837839
266 Yamamoto  H, Sakamoto  H, Kumagai  H, Abe  T, Ishiguro  S, Uchida  K  et al  Clinical guidelines for diagnosis and management of Peutz-Jeghers syndrome in children and adults. Digestion  2023;104 :335–347 37054692
267 Correa  H . Li–Fraumeni syndrome. J Pediatr Genet  2016;5 :84–88 27617148
268 FUSE Study . SIOP FUSE Study. [cited14 Sep 2033]. Available at: https://siop-online.org/wp-content/uploads/2023/01/FUSE-study-1-1.pdf
269 Losty  PD . The challenges of surgical research in children. Br J Surg  2017;104 :1589–1590 29044487
270 Sampat  K, Losty  PD. Transitional care and paediatric surgery. Br J Surg  2016;103 :163–164 26785645
271 Tan  JK, Banton  G, Minutillo  C, Hall  GL, Wilson  A, Murray  C  et al  Long-term medical and psychosocial outcomes in congenital diaphragmatic hernia survivors. Arch Dis Child  2019;104 :761–767 30877092
272 Caplan  A . Psychological impact of esophageal atresia: review of the research and clinical evidence. Dis Esophagus  2013;26 :392–400 23679030
273 Langeveld  NE, Grootenhuis  MA, Voûte  PA, De Haan  RJ, Van Den Bos  C. Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology  2004;13 :867–881 15386796
274 Svetanoff  WJ, Kapalu  CL, Lopez  JJ, Fraser  JA, Briggs  KB, Rentea  RM.  Psychosocial factors affecting quality of life in patients with anorectal malformation and Hirschsprung disease–a qualitative systematic review. J Pediatr Surg  2022;57 :387–393 34127258
